Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3010726	s-hevohie	— (—)	3402	3511	100.00%	Distribution not available
3010726	s-hevohie	u/ml (u/ml)	2132	2273	4.71%
3010726	s-hevonee	u/ml (—)	1689	1769	100.00%	Distribution not available
3010726	hevonen	— (—)	614	647	100.00%	Distribution not available
3010726	hevonee	u/ml (—)	163	174	100.00%	Distribution not available
3010726	s-hevonhie	u/ml (—)	124	125	100.00%	Distribution not available
3010726	igehevonen	u/ml (—)	122	128	100.00%	Distribution not available
3010726	s-hevosenhilse,igevasta-aineet	u/ml (—)	98	100	100.00%	Distribution not available
3010726	hevonen	u/ml (u/ml)	81	82	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic rhinitis, nasopharyngitis and pharyngitis

788

1796

4.55

316.54

1.1

1.0

0.92

1.95

u/ml

4.05

449

769

Atopic dermatitis, strict definition with reimbursement

1130

3234

3.55

312.47

1.2

1.1

4.16

1.99

u/ml

6.52

832

1558

Asthma and allergy

998

944

11.94

307.65

1.2

1.0

3.89

1.62

u/ml

6.07

769

390

Disorders of conjunctiva

1992

5817

2.82

307.65

1.1

2.57

1.99

u/ml

1.42

1210

2812

Allergic conjunctivitis

1693

5026

3.41

307.65

1.1

2.54

1.89

u/ml

1.60

1052

2368

Allergic asthma (mode), excluding more controls

1345

1507

9.56

307.65

1.2

1.0

3.52

2.10

u/ml

2.49

1024

610

Asthma

2476

2321

5.82

307.65

1.1

1.0

2.57

1.81

u/ml

1.65

1534

886

Asthma (only as main-diagnosis)

2407

2321

6.27

307.65

1.1

1.0

2.59

1.81

u/ml

1.70

1513

886

Asthma (only as main-diagnosis), excluding more controls

2398

2299

6.24

307.65

1.1

1.0

2.59

1.83

u/ml

1.62

1509

874

Other diseases of upper respiratory tract

2065

3675

2.98

307.65

1.1

1.0

2.02

2.21

u/ml

0.29

1213

1587

Desensitization to allergens

496

660

9.21

307.65

1.1

2.26

2.28

u/ml

0.02

370

346

Asthma, hospital admissions , main diagnosis only

2587

5330

4.46

307.65

1.1

1.0

2.82

1.62

u/ml

5.27

1667

2395

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1638

4735

3.49

307.65

1.1

2.40

1.81

u/ml

1.49

1014

2222

Allergic asthma (mode)

1345

1507

9.57

307.65

1.2

1.0

3.52

2.10

u/ml

2.49

1024

609

Vasomotor and allergic rhinitis

2086

2833

7.90

307.65

1.1

1.0

2.79

2.45

u/ml

0.48

1404

1252

Asthma, excluding more controls

2454

2299

5.80

307.65

1.1

1.0

2.58

1.83

u/ml

1.58

1522

874

Asthma-related infections

1596

3710

4.37

307.65

1.2

1.1

2.93

1.46

u/ml

5.44

1055

1689

Pollen allergy

1609

2022

9.25

307.65

1.2

1.1

2.88

1.86

u/ml

2.58

1120

983

Asthma, unspecified (mode), excluding more controls

1122

2003

4.31

307.65

1.1

1.0

1.49

1.65

u/ml

0.22

580

757

Asthma and allergy, excluding more controls

1000

957

11.81

307.65

1.2

1.0

3.88

1.57

u/ml

6.32

771

399

Chronic lower respiratory diseases

3287

4659

3.87

307.65

1.1

1.0

2.66

1.53

u/ml

5.55

1970

2061

Atopic dermatitis

1755

4848

3.07

307.65

1.1

3.43

1.74

u/ml

6.68

1123

2223

Asthma, including avohilmo

3557

4327

4.79

307.65

1.1

1.0

2.71

1.36

u/ml

7.97

2081

1921

Asthma (mode)

2489

2328

5.97

307.65

1.1

1.0

2.64

1.80

u/ml

1.93

1548

890

Chronic sinusitis

942

2344

4.14

307.65

1.1

1.0

0.97

2.09

u/ml

4.26

519

966

1386

3143

4.57

307.65

1.2

1.1

3.10

1.56

u/ml

4.80

918

1471

Asthma (diagnoses ohter than nonallergic)

2683

5188

4.46

307.65

1.1

1.0

2.78

1.65

u/ml

4.85

1746

2302

Asthma/COPD (KELA code 203)

2635

4634

4.03

307.65

1.1

1.0

2.83

1.54

u/ml

6.31

1607

2054

Conjunctivitis

1957

5691

2.96

307.65

1.1

2.57

2.02

u/ml

1.29

1192

2759

Asthma, unspecified (mode)

1125

2018

4.31

307.65

1.1

1.0

1.49

1.63

u/ml

0.19

581

767

Asthma, hospital admission 2, infections

1596

3710

4.37

307.65

1.2

1.1

2.93

1.46

u/ml

5.44

1055

1689

Allergic rhinitis

2008

2817

7.88

307.65

1.2

1.1

2.80

1.71

u/ml

3.85

1377

1288

Obesity related asthma

745

1704

4.53

297.70

1.1

1.0

2.31

1.20

u/ml

2.04

436

697

Suggestive for eosinophilic asthma

304

282

11.61

286.32

1.2

1.0

1.16

1.35

u/ml

0.17

226

118

Dermatitis and eczema

2154

5587

2.43

278.20

1.1

2.87

1.59

u/ml

5.37

1319

2545

Nasal polyp

439

668

6.86

275.64

1.2

1.0

1.09

1.58

u/ml

0.73

298

277

Other pulmonary diagnosis

1380

2358

2.98

244.59

1.1

1.0

1.82

1.88

u/ml

0.06

767

901

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

920

2704

3.38

243.60

1.1

1.0

1.39

2.11

u/ml

1.66

482

1101

Atopic dermatitis, strict definition

1082

3586

3.10

241.24

1.1

4.31

2.09

u/ml

6.42

805

1821

COPD differential diagnosis

1355

2328

2.96

237.96

1.1

1.0

1.83

1.80

u/ml

0.03

757

890

ILD differential diagnosis

1355

2328

2.96

237.95

1.1

1.0

1.83

1.80

u/ml

0.03

757

890

Excluding asthma or asthma-COPD overlap

1358

2358

2.93

234.31

1.1

1.0

1.84

1.88

u/ml

0.05

758

901

Childhood asthma (age<16)

594

1052

4.72

226.71

1.1

1.0

4.18

2.29

u/ml

2.58

439

457

Childhood asthma (age<16), excluding more controls

594

1053

4.72

226.28

1.1

1.0

4.18

2.29

u/ml

2.58

439

457

Oral corticosteroids

1891

5119

2.22

198.38

1.1

2.42

1.76

u/ml

1.85

1094

2369

Asthma-related pneumonia or sepsis

602

1597

3.85

195.60

1.1

2.55

1.51

u/ml

1.64

403

725

Asthma, hospital admissions 3, pneumonia

602

1597

3.85

195.60

1.1

2.55

1.51

u/ml

1.64

403

725

Asthma-related pneumonia

600

1589

3.86

195.44

1.1

2.55

1.50

u/ml

1.66

402

717

Cough

808

2500

3.13

187.31

1.1

1.74

2.30

u/ml

0.60

462

1236

ILD medications: prednisolone, methylprednisolone, prednisone

1975

5243

2.14

185.19

1.1

2.50

1.83

u/ml

1.90

1146

2499

Undetermined asthma

294

483

6.33

171.22

1.1

1.0

0.86

1.20

u/ml

0.56

167

180

Diseases of the respiratory system

998

1741

2.91

171.02

1.1

1.0

1.84

1.79

u/ml

0.05

543

678

Undetermined asthma, excluding more controls

294

485

6.30

170.51

1.1

1.0

0.86

1.20

u/ml

0.56

167

180

Biological medicines for asthma

156

120

16.24

169.17

1.3

1.0

3.81

1.88

u/ml

0.85

117

Childhood allergy (age < 16)

725

2020

3.15

157.03

1.2

1.1

3.94

2.57

u/ml

2.16

569

1063

Abnormalities of breathing

1694

4756

2.10

153.46

1.1

2.02

2.24

u/ml

0.36

938

2297

ILD medications

2000

5543

1.98

152.72

1.1

2.44

1.92

u/ml

1.27

1154

2698

Deviated nasal septum

475

1342

3.61

140.95

1.1

1.0

1.36

2.00

u/ml

0.91

255

525

Inflammatory bowel disease treatment related agents

1957

5731

1.93

140.69

1.1

2.37

1.93

u/ml

1.01

1124

2766

FESS (DNB20)

339

779

4.57

135.84

1.2

1.1

0.68

1.47

u/ml

2.80

203

365

Ethmoidectomy

342

799

4.49

134.10

1.2

1.1

0.68

1.46

u/ml

2.84

205

372

Symptoms and signs involving the circulatory and respiratory systems

1832

4788

1.94

129.46

1.1

1.86

2.23

u/ml

0.83

1012

2311

First line medication for Crohn's disease

1896

5490

1.89

126.22

1.1

2.42

1.93

u/ml

1.18

1099

2661

Chronic diseases of tonsils and adenoids

1227

3616

2.17

124.35

1.1

1.0

1.71

2.25

u/ml

1.12

655

1559

Adverse effects, not elsewhere classified

543

1818

3.11

123.88

1.1

3.22

1.92

u/ml

1.77

384

939

Dermatitis due to ingested food

272

556

5.45

121.92

1.2

1.1

4.80

2.55

u/ml

1.73

227

340

Urticaria

666

2878

2.37

90.65

1.1

2.01

2.15

u/ml

0.15

429

1486

Other and unspecified effects of external causes

640

2731

2.41

89.78

1.1

3.02

2.12

u/ml

1.18

436

1407

Other medical care

588

2147

2.50

89.14

1.1

2.40

1.79

u/ml

0.83

412

1036

Urticaria and erythema

726

3352

2.21

84.06

1.1

2.20

2.10

u/ml

0.10

466

1733

Acute upper respiratory infections

1516

5398

1.75

81.47

1.1

2.08

2.01

u/ml

0.09

818

2650

Personal history of allergy to drugs, medicaments and biological substances

13.72

80.70

1.4

1.1

0.40

1.39

u/ml

0.90

Dyspnoea

1231

5069

1.81

77.82

1.1

1.74

2.00

u/ml

0.47

697

2475

Diseases of the skin and subcutaneous tissue

1496

4318

1.75

77.81

1.1

2.15

1.72

u/ml

0.91

891

1887

Acute upper respiratory infections of multiple and unspecified sites

1233

5156

1.79

75.04

1.1

2.30

2.08

u/ml

0.29

672

2533

Bronchitis

1584

6034

1.67

72.52

1.1

2.16

1.89

u/ml

0.46

856

2965

Insomnia

1386

5966

1.71

71.50

1.1

1.88

2.01

u/ml

0.17

645

2962

Asthma mixed form (mode)

116

182

6.64

71.01

1.2

1.0

1.93

1.38

u/ml

0.31

Any reimbursement code in KELA

1245

3501

1.81

70.96

1.1

2.58

1.62

u/ml

2.48

731

1568

Asthma mixed form (mode), excluding more controls

116

183

6.60

70.62

1.2

1.0

1.93

1.38

u/ml

0.31

Non-allergic asthma (mode)

255

756

3.40

69.44

1.1

1.0

0.88

1.64

u/ml

1.41

122

310

Non-allergic asthma (mode), excluding more controls

255

762

3.37

68.58

1.1

1.0

0.88

1.62

u/ml

1.37

122

316

Diseases of the eye and adnexa

1472

4393

1.70

67.95

1.1

2.12

2.21

u/ml

0.11

847

2123

D07AA Corticosteroids, weak (group I)

420

1691

2.57

67.25

1.2

1.1

5.47

2.14

u/ml

5.22

321

923

Sleep disorders

1375

5993

1.67

65.57

1.1

1.80

2.05

u/ml

0.40

648

2987

1556

4944

1.64

63.95

1.1

2.17

1.84

u/ml

0.57

828

2380

Acute sinusitis

882

4454

1.86

62.70

1.1

1.87

1.83

u/ml

0.05

456

2147

Sleep apnoea, including avohilmo

1262

4686

1.68

59.65

1.1

1.83

1.64

u/ml

0.27

612

2244

Polypectomy (DHB20)

132

276

4.98

59.51

1.2

1.1

0.65

1.68

u/ml

1.71

129

Early onset COPD, excluding more controls

175

468

3.78

56.58

1.1

1.0

2.09

1.20

u/ml

1.04

104

157

Behavioural syndromes associated with physiological disturbances and physical factors

1384

6211

1.59

54.31

1.1

1.94

2.15

u/ml

0.33

677

3162

Dermatitis

739

4004

1.86

53.60

1.1

2.00

1.41

u/ml

0.84

450

1795

Other acute lower respiratory infections

772

4053

1.84

53.40

1.2

1.1

3.05

2.06

u/ml

1.39

464

2142

Sleep disorders (combined)

1566

5342

1.55

51.43

1.1

1.82

2.14

u/ml

0.60

771

2717

Chronic laryngitis and laryngotracheitis

166

466

3.63

50.25

1.1

1.0

1.27

1.49

u/ml

0.18

189

Allergic contact dermatitis

254

944

2.76

47.92

1.1

1.38

1.11

u/ml

0.34

167

412

Diarrhoea and gastroenteritis of presumed infectious origin

1424

6165

1.53

46.83

1.1

1.87

2.16

u/ml

0.52

744

3111

Voice disturbances

353

1550

2.31

46.37

1.2

1.1

1.23

1.37

u/ml

0.18

191

733

Asthma and opportunity respiratory infection

7.74

44.74

1.1

1.0

0.87

1.05

u/ml

0.09

Other and unspecified urticaria

382

1782

2.19

43.58

1.1

1.85

2.04

u/ml

0.16

233

911

Bronchiectasis

118

6.22

42.12

1.1

0.81

1.02

u/ml

0.13

Pain in joint

866

3301

1.69

41.99

1.1

1.43

2.20

u/ml

1.97

472

1668

Sleep apnoea

1076

4413

1.59

41.40

1.1

1.70

1.54

u/ml

0.21

528

2095

Other and unspecified dermatitis

601

3328

1.82

41.32

1.1

1.80

1.38

u/ml

0.50

369

1527

Dentofacial anomalies [including malocclusion]

1135

5909

1.56

41.28

1.1

1.68

2.24

u/ml

1.43

601

2945

COPD/asthma related infections

1406

4713

1.50

40.05

1.1

2.11

1.83

u/ml

0.47

748

2281

COPD/asthma/ILD related infections

1406

4713

1.50

40.05

1.1

2.11

1.83

u/ml

0.47

748

2281

Idiopathic urticaria

155

5.60

40.00

1.2

1.1

1.38

2.80

u/ml

0.81

Symptoms and signs involving speech and voice

380

1874

2.05

37.20

1.1

1.32

1.30

u/ml

0.03

204

903

Medical observation and evaluation for suspected diseases and conditions

931

2961

1.62

36.91

1.1

1.42

2.20

u/ml

2.47

569

1335

Migraine

893

4566

1.60

36.87

1.1

1.69

2.28

u/ml

1.09

435

2336

Dermatographic urticaria

158

527

3.12

36.77

1.2

1.1

1.46

1.76

u/ml

0.24

104

251

Headache

1016

5307

1.54

35.52

1.1

1.67

2.25

u/ml

0.96

528

2644

COPD

230

756

2.50

35.12

1.1

1.0

1.72

0.96

u/ml

1.23

131

315

Intestinal infectious diseases

1505

6051

1.43

34.15

1.1

1.82

2.16

u/ml

0.69

769

3052

Recurrent or chronic depression

624

2559

1.73

33.99

1.1

2.18

1.95

u/ml

0.26

319

1227

Triptan medication for migraine, single purchase ok

1199

5532

1.48

33.56

1.1

1.80

2.17

u/ml

0.75

580

2802

Migraine, single triptan purchase ok & required. ICD-code if available is included

1199

5532

1.48

33.56

1.1

1.80

2.17

u/ml

0.75

580

2802

Acute bronchitis

498

2728

1.81

33.29

1.1

2.46

1.92

u/ml

0.58

276

1424

Other chronic obstructive pulmonary disease

216

714

2.51

33.24

1.1

1.0

1.78

0.81

u/ml

1.76

125

293

Gastro-oesophageal reflux disease

776

4234

1.59

31.85

1.1

1.23

1.89

u/ml

1.82

363

2082

Special screening examination for infectious and parasitic diseases

516

2151

1.79

31.69

1.1

1.0

1.67

2.22

u/ml

0.61

271

924

Any death

1962

0.28

30.85

1.0

1.1

0.70

1.22

u/ml

0.66

974

Episodal and paroxysmal disorders

1544

5662

1.40

30.04

1.1

2.28

2.20

u/ml

0.09

791

2934

Depression or dysthymia

823

2903

1.58

29.77

1.1

1.83

1.96

u/ml

0.17

431

1427

Abnormalities of heart beat

401

2133

1.86

29.58

1.1

1.51

2.00

u/ml

0.60

202

1020

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

621

1861

1.69

28.84

1.1

1.93

2.37

u/ml

0.63

322

920

Neurotic, stress-related and somatoform disorders

1259

6269

1.41

28.05

1.1

1.90

2.11

u/ml

0.37

707

3047

Anxiety disorders

1261

6270

1.41

27.67

1.1

1.90

2.11

u/ml

0.37

708

3047

Eosinophilic disease (BM)

9.65

27.62

1.3

1.0

2.13

0.49

u/ml

0.44

Exposure to unspecified factor

1319

6840

1.40

27.42

1.1

1.97

2.14

u/ml

0.27

718

3455

Other special examinations and investigations of persons without complaint or reported diagnosis

884

2961

1.52

26.96

1.1

1.90

2.20

u/ml

0.46

492

1335

Pain in throat and chest

1048

4350

1.45

26.67

1.1

1.69

2.11

u/ml

0.94

538

2056

Atopic conjunctivitis

109

359

3.16

26.12

1.1

4.45

1.56

u/ml

1.22

206

Irritable bowel syndrome

390

2187

1.81

26.10

1.1

1.91

1.64

u/ml

0.20

200

1076

Pain (limb, back, neck, head abdominally)

1002

3450

1.46

25.35

1.1

2.02

2.20

u/ml

0.22

532

1781

Malignant neoplasm

472

4588

0.60

24.78

1.1

1.43

1.63

u/ml

0.25

220

2217

Examination and observation for other reasons

770

2945

1.52

24.35

1.1

1.35

2.21

u/ml

2.51

447

1327

All anxiety disorders

1009

5642

1.42

23.89

1.1

1.87

2.24

u/ml

0.68

587

2763

Temporomandibular joint disorders, including avohilmo

728

4807

1.51

23.83

1.1

1.50

2.29

u/ml

2.47

401

2389

Conjunctivitis (acute, non atopic)

399

2306

1.74

23.81

1.1

2.65

2.09

u/ml

0.49

233

1197

Any event in cancer register

597

5423

0.64

23.70

1.1

1.87

1.71

u/ml

0.16

272

2652

Caries of enamel

1210

6373

1.38

23.40

1.1

1.89

2.11

u/ml

0.35

666

3142

Diabetes, insulin treatment (Kela reimbursement)

578

5402

0.64

23.30

1.1

1.22

1.88

u/ml

1.64

292

2667

Solid cancers, helper endpoint

460

4401

0.61

22.82

1.1

1.47

1.53

u/ml

0.07

212

2104

Anxiety (asthma-related co-morbidities)

977

5377

1.42

22.40

1.1

1.88

2.24

u/ml

0.63

568

2605

Malignant neoplasm, wide definition for exclusion

534

4875

0.64

22.17

1.1

1.46

1.72

u/ml

0.39

250

2357

Anxiety disorders, excluding more controls

1116

5265

1.39

22.15

1.1

1.92

2.12

u/ml

0.28

627

2509

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

568

5249

0.65

22.02

1.1

1.24

1.90

u/ml

1.59

287

2589

Abnormal findings on diagnostic imaging of lung

308

1652

1.80

20.59

1.1

1.25

1.18

u/ml

0.08

156

791

Persons encountering health services for examination and investigation

847

2961

1.44

20.04

1.1

1.62

2.20

u/ml

1.38

470

1335

Triptan medication for migraine, min. 3 purchases

929

5101

1.40

20.03

1.1

1.50

2.14

u/ml

1.58

432

2528

Diabetes medication

726

6182

0.69

20.00

1.1

1.33

1.93

u/ml

1.70

378

3038

Other headache syndromes

533

3468

1.55

19.98

1.1

2.19

1.89

u/ml

0.21

276

1683

Coxibs

332

976

1.81

19.92

1.1

2.98

2.49

u/ml

0.33

149

558

Diabetes mellitus

741

6192

0.70

19.87

1.1

1.44

1.97

u/ml

1.33

387

3056

Diabetes, varying definitions

734

6153

0.70

19.71

1.1

1.45

1.96

u/ml

1.23

382

3033

Other disorders of lacrimal gland

359

2133

1.70

19.67

1.1

1.99

1.42

u/ml

0.50

175

1016

Tonsillectomy and adenotomy

1059

5427

1.37

19.58

1.1

2.35

2.27

u/ml

0.09

573

2819

Disorders of lacrimal system

429

2667

1.62

19.45

1.1

1.91

1.66

u/ml

0.21

209

1286

Codeine

1220

4954

1.34

19.41

1.1

1.18

1.98

u/ml

3.97

608

2392

Opioids

1314

5156

1.33

19.26

1.1

1.62

2.12

u/ml

1.17

661

2514

Acetic acid derivatives and related substances

320

926

1.81

19.25

1.1

2.62

1.96

u/ml

0.48

150

521

Bronchitis, not specified as acute or chronic

310

2.91

19.19

1.1

1.0

1.87

1.49

u/ml

0.25

127

Codeine or tramadol medication

1354

5647

1.32

18.80

1.1

1.21

1.97

u/ml

3.88

673

2712

Soft tissue disorders

1424

5626

1.31

18.66

1.1

2.10

2.27

u/ml

0.24

755

2897

Low back pain

943

4938

1.38

18.48

1.1

1.47

2.04

u/ml

1.30

477

2388

Early onset COPD

175

846

2.09

18.38

1.1

1.0

2.09

1.15

u/ml

1.23

104

397

Other antidepressants

1220

4704

1.33

18.30

1.1

1.94

2.11

u/ml

0.25

634

2284

COPD (mode)

127

414

2.42

18.26

1.0

1.40

1.08

u/ml

0.30

153

Other dorsopathies, not elsewhere classified

1337

5347

1.31

18.13

1.1

1.82

2.23

u/ml

0.74

715

2642

Acute bronchiolitis

205

954

2.01

18.12

1.2

1.1

5.70

2.46

u/ml

2.07

156

642

Mycoses

1041

6763

1.35

17.98

1.1

1.86

2.05

u/ml

0.26

508

3401

Allergic urticaria

154

720

2.19

17.90

1.1

2.79

1.96

u/ml

0.48

100

379

Diseases of the musculoskeletal system and connective tissue

951

3468

1.38

17.85

1.1

2.52

2.51

u/ml

0.01

508

1836

Neurological diseases

1281

4902

1.32

17.69

1.1

2.18

2.26

u/ml

0.09

671

2576

Other anxiety disorders

771

4777

1.41

17.67

1.1

1.86

2.32

u/ml

0.76

464

2354

Simple and mucopurulent chronic bronchitis

4.55

17.55

1.1

0.24

0.72

u/ml

0.85

Renal tubulo-interstitial diseases

512

5669

0.67

17.49

1.1

1.44

2.08

u/ml

1.42

286

2846

Depression

1221

6319

1.32

17.44

1.1

1.86

2.17

u/ml

0.66

691

3060

Diseases of middle ear and mastoid

889

5332

1.37

17.31

1.1

1.82

2.31

u/ml

0.88

493

2761

Dorsalgia

1285

5285

1.31

16.95

1.1

1.57

2.13

u/ml

1.41

679

2600

Myalgia

311

1855

1.69

16.94

1.1

2.63

1.78

u/ml

0.50

170

897

Persons encountering health services for specific procedures and health care

1387

6470

1.29

16.90

1.1

1.95

2.20

u/ml

0.41

862

3160

Candidiasis

358

2230

1.62

16.45

1.1

1.65

1.85

u/ml

0.17

177

1136

Eosinophilia

5.40

16.45

1.3

1.1

2.13

2.26

u/ml

0.02

All kidney diseases

709

6723

0.72

16.31

1.1

1.63

2.11

u/ml

0.92

390

3371

Haemorrhage from respiratory passages

239

1203

1.80

16.10

1.1

1.0

2.53

1.94

u/ml

0.33

135

569

Selective serotonin reuptake inhibitors

1205

4825

1.31

15.97

1.1

1.64

2.22

u/ml

1.65

624

2379

Pain and other conditions associated with female genital organs and menstrual cycle

366

2122

1.61

15.87

1.1

1.35

2.37

u/ml

1.63

179

1095

Other specific joint derangements/joint disorders

1070

5260

1.32

15.72

1.1

1.71

2.35

u/ml

1.43

562

2674

Abdominal and pelvic pain

1255

4880

1.30

15.44

1.1

1.76

2.29

u/ml

1.14

628

2528

Certain infectious and parasitic diseases

955

3570

1.35

15.24

1.1

1.77

2.15

u/ml

0.64

489

1789

Dorsopathies

1380

5510

1.28

15.18

1.1

1.89

2.25

u/ml

0.66

723

2777

Mood [affective] disorders

1253

6343

1.29

15.06

1.1

1.73

2.16

u/ml

1.07

700

3080

Other soft tissue disorders, not elsewhere classified

1204

5476

1.29

15.00

1.1

2.10

2.25

u/ml

0.18

631

2803

Gastrointestinal diseases

994

3751

1.34

14.98

1.1

2.19

2.45

u/ml

0.32

538

1927

Soft tissue disorders related to use, overuse and pressure

245

1418

1.74

14.92

1.1

0.93

1.55

u/ml

1.08

117

642

Parasetamol

1093

4233

1.31

14.85

1.1

2.24

2.42

u/ml

0.20

570

2126

Symptoms and signs involving the digestive system and abdomen

1251

4880

1.29

14.75

1.1

1.78

2.29

u/ml

1.09

626

2528

Exposure to other specified factors

962

6729

1.32

14.72

1.1

2.56

2.05

u/ml

0.66

536

3400

Migraine with aura

402

2645

1.54

14.65

1.1

1.68

2.21

u/ml

0.55

205

1339

Mood disorders

1251

6345

1.28

14.64

1.1

1.74

2.16

u/ml

1.06

699

3081

Cystitis

1011

4574

1.32

14.62

1.1

2.03

1.99

u/ml

0.04

507

2316

Propionic acid derivatives

383

1220

1.59

14.47

1.1

2.27

2.75

u/ml

0.43

206

756

Allergic colitis

100

435

2.45

14.35

1.2

1.1

3.85

3.09

u/ml

0.28

304

Type 2 diabetes

652

5257

0.72

14.33

1.1

1.26

1.68

u/ml

1.09

328

2468

Lichen simplex chronicus and prurigo

239

2.85

13.98

1.1

1.44

0.80

u/ml

0.58

112

Other (not insulin) diabetes medications

591

4891

0.71

13.92

1.1

1.21

1.65

u/ml

1.11

301

2291

Other chronic obstructive pulmonary disease, including avohilmo

296

1510

1.63

13.68

1.1

1.58

1.06

u/ml

0.96

173

721

Dysphagia

194

1078

1.81

13.63

1.1

0.97

1.21

u/ml

0.43

102

546

Other joint disorders

1297

5416

1.27

13.58

1.1

1.74

2.33

u/ml

1.54

674

2765

Other bacterial diseases

581

5422

0.72

13.50

1.1

2.39

1.77

u/ml

0.94

330

2721

Biguanides

555

4731

0.71

13.35

1.1

1.14

1.58

u/ml

1.08

280

2213

Type 2 diabetes, definitions combined, including avohilmo

604

4851

0.72

13.27

1.1

1.32

1.65

u/ml

0.74

305

2268

ILD, hospital admissions 1, main diag only

327

2.50

13.20

1.1

1.61

1.11

u/ml

0.28

169

Mouth breathing

424

2882

1.48

13.10

1.1

1.83

2.03

u/ml

0.16

231

1521

Other bacterial diseases

732

6185

0.75

12.87

1.1

2.27

1.92

u/ml

0.49

416

3093

Schizophrenia

1342

0.35

12.62

1.0

1.1

1.09

2.08

u/ml

1.33

671

Insulin medication

292

3812

0.64

12.62

1.1

1.20

1.88

u/ml

1.08

160

1963

Symptoms and signs involving the skin and subcutaneous tissue

756

5583

1.33

12.58

1.1

1.88

1.82

u/ml

0.06

402

2761

Migraine with aura and triptan purchases

280

1765

1.61

12.50

1.1

1.96

1.79

u/ml

0.10

146

918

Viral infections characterized by skin and mucous membrane lesions

1032

6930

1.28

12.48

1.1

2.43

2.06

u/ml

0.48

528

3543

Depression medications

635

2315

1.39

12.42

1.1

2.58

2.81

u/ml

0.19

333

1161

Anti-inflammatory and antirheumatic products, non-steroids

372

1223

1.54

12.34

1.1

2.10

2.77

u/ml

0.72

199

759

Schizophrenia, schizotypal and delusional disorders

159

2837

0.56

12.32

1.1

0.72

1.95

u/ml

6.14

101

1408

Suppurative and unspecified otitis media

637

4166

1.37

12.30

1.1

1.83

2.47

u/ml

1.23

365

2235

Herpesviral [herpes simplex] infections

341

2253

1.53

12.28

1.1

3.08

1.67

u/ml

1.12

184

1129

Type 2 diabetes, definitions combined

595

4767

0.73

12.27

1.1

1.29

1.60

u/ml

0.65

299

2224

Type 2 diabetes, strict (exclude DM1)

596

4773

0.73

12.25

1.1

1.28

1.60

u/ml

0.69

300

2226

Schizophrenia or delusion

159

2829

0.56

12.21

1.1

0.72

1.96

u/ml

6.16

101

1405

Neurological diseases, wide definition

596

2153

1.40

12.19

1.1

2.02

2.78

u/ml

1.02

320

1204

Paracetamol or NSAID medication

278

858

1.65

12.15

1.1

2.31

3.06

u/ml

0.60

160

541

Accidents

1060

4156

1.28

12.12

1.1

1.96

2.13

u/ml

0.23

563

2012

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

494

3135

1.42

12.01

1.1

1.31

1.44

u/ml

0.16

261

1529

Chronic conjunctivitis

183

2.99

11.89

1.1

4.76

1.62

u/ml

0.89

108

Malignant neoplasm of breast, HER2-negative

171

1947

0.57

11.75

1.1

1.54

1.23

u/ml

0.22

877

COPD, hospital admissions

215

1079

1.69

11.69

1.1

1.0

1.78

0.98

u/ml

1.29

125

512

Pruritus

118

588

2.03

11.67

1.1

1.96

0.83

u/ml

0.60

262

ILD, hospital admissions

378

2.29

11.65

1.1

1.58

1.11

u/ml

0.27

199

Other interstitial pulmonary diseases

378

2.29

11.65

1.1

1.58

1.10

u/ml

0.27

200

Injuries to the wrist and hand

1216

6783

1.25

11.58

1.1

2.72

1.95

u/ml

1.20

651

3426

Interstitial lung disease endpoints

379

2.29

11.58

1.1

1.58

1.10

u/ml

0.27

200

Interstitial lung disease

379

2.29

11.58

1.1

1.58

1.10

u/ml

0.27

200

Other external causes of accidental injury

1054

4156

1.28

11.54

1.1

1.95

2.13

u/ml

0.25

565

2012

Malignant neoplasm of breast, including Hilmo

189

2063

0.59

11.50

1.1

1.46

1.21

u/ml

0.19

924

COPD, early/later onset

216

1087

1.68

11.50

1.1

1.0

1.78

0.98

u/ml

1.29

125

516

Malignant neoplasm of breast, HER2-negative, including Hilmo

189

2063

0.59

11.50

1.1

1.46

1.21

u/ml

0.19

924

Malignant neoplasm of breast

178

1987

0.58

11.49

1.1

1.51

1.22

u/ml

0.21

892

Vocal cord dysfunction

183

942

1.76

11.49

1.2

1.1

1.70

1.50

u/ml

0.10

428

Lower back pain or/and sciatica

1189

6241

1.25

11.41

1.1

1.50

2.01

u/ml

1.19

609

3035

Mood disorders, excluding more controls

1104

5251

1.26

11.29

1.1

1.86

2.12

u/ml

0.46

610

2482

Acute pharyngitis

272

1731

1.58

11.28

1.1

2.93

2.66

u/ml

0.13

155

959

Other respiratory diseases principally affecting the interstitium

466

2.12

10.96

1.1

1.45

1.19

u/ml

0.14

250

Nummular dermatitis

296

2.43

10.91

1.1

1.73

0.85

u/ml

0.31

136

Heartburn

126

659

1.93

10.89

1.1

0.53

1.74

u/ml

2.88

337

Prurigo nodularis

4.39

10.82

1.0

1.12

0.53

u/ml

0.42

Diseases of the ear and mastoid process

1466

6056

1.22

10.80

1.1

1.75

2.13

u/ml

0.87

773

3021

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1319

5844

1.23

10.79

1.1

1.87

2.14

u/ml

0.50

751

2880

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

296

2.22

10.77

1.1

1.52

1.29

u/ml

0.12

147

Intestinal infectious diseases

1123

6880

1.24

10.63

1.1

2.13

u/ml

0.00

612

3481

Diseases of oesophagus, stomach and duodenum

1184

5727

1.24

10.62

1.1

1.34

2.00

u/ml

2.59

606

2825

Functional dyspepsia

263

1700

1.56

10.51

1.1

1.46

1.47

u/ml

0.01

135

821

Kela-code for severe mental illness

196

3172

0.61

10.46

1.1

0.76

1.92

u/ml

4.72

120

1567

Oxicams

190

630

1.72

10.27

1.1

0.74

1.54

u/ml

1.96

344

Other general symptoms and signs

110

558

2.00

10.25

1.1

2.63

2.59

u/ml

0.01

342

Other noninfective gastroenteritis and colitis

292

1943

1.51

10.21

1.1

2.70

2.41

u/ml

0.18

186

1068

Other and unspecified nonorganic psychotic disorders

111

2071

0.53

10.20

1.1

0.64

2.15

u/ml

6.58

1048

Other inflammation of eyelid

140

775

1.83

10.16

1.1

2.11

1.70

u/ml

0.21

391

Other viral diseases

597

4474

1.33

10.13

1.1

1.95

2.42

u/ml

0.54

313

2414

General symptoms and signs

1362

5617

1.22

10.04

1.1

1.54

2.21

u/ml

2.18

733

2807

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

111

573

1.96

10.03

1.1

1.53

1.74

u/ml

0.13

292

Disorders of skin appendages

613

4652

1.32

9.94

1.1

2.01

2.20

u/ml

0.19

358

2366

Other diseases of hard tissues of teeth

571

2189

1.35

9.84

1.1

1.56

1.91

u/ml

0.52

288

1044

Schizophrenia or delusion, excluding more controls

159

2637

0.59

9.83

1.1

0.72

1.84

u/ml

5.03

101

1263

Somatoform disorder

200

1234

1.64

9.82

1.1

0.93

1.71

u/ml

2.15

107

571

Disturbances of skin sensation

343

2381

1.45

9.75

1.1

2.12

1.74

u/ml

0.31

185

1153

Fenamates

150

573

1.79

9.60

1.1

1.62

1.71

u/ml

0.03

312

Mental and behavioural disorders due to alcohol, excluding acute intoxication

195

3073

0.63

9.50

1.1

2.48

1.83

u/ml

0.37

119

1485

Non-allergic asthma

354

2.20

9.47

1.1

1.0

0.68

1.58

u/ml

0.70

159

Trochanteric bursitis

117

627

1.88

9.43

1.1

0.39

1.55

u/ml

3.40

280

Enthesopathies of lower limb, excluding foot

234

1513

1.56

9.41

1.1

2.20

1.58

u/ml

0.46

121

708

Provisional assignment of new diseases of uncertain etiology

591

4496

1.32

9.39

1.1

2.02

1.95

u/ml

0.06

327

2311

Persons encountering health services in other circumstances, wide

1368

5844

1.21

9.37

1.1

1.98

2.14

u/ml

0.25

751

2880

Follow-up examination after treatment for conditions other than malignant neoplasms

493

2404

1.36

9.28

1.1

1.11

1.98

u/ml

2.70

252

1062

Codes for special purposes

591

4504

1.32

9.28

1.1

2.02

1.95

u/ml

0.06

327

2314

All chronic kidney diseases

230

2862

0.65

9.20

1.0

1.1

1.93

2.07

u/ml

0.11

126

1511

Disorders of synovium and tendon

569

3780

1.32

9.20

1.1

1.51

1.89

u/ml

0.46

261

1811

External causes of morbidity and mortality

887

3532

1.26

9.13

1.1

1.93

2.16

u/ml

0.33

470

1719

Chronic gastritis

148

860

1.73

9.08

1.1

1.0

0.74

1.24

u/ml

0.90

402

Renal failure

1556

0.52

9.07

1.0

1.1

1.13

1.46

u/ml

0.34

799

Acute suppurative otitis media

506

3541

1.35

9.05

1.1

2.25

2.58

u/ml

0.31

297

1931

Other and unspecified rosacea

476

2.00

9.02

1.1

1.10

1.60

u/ml

0.64

208

Infective dermatitis

100

517

1.95

9.01

1.1

2.26

1.10

u/ml

0.50

217

Alcohol use disorder, ICD-based

180

2860

0.63

8.94

1.1

2.46

1.85

u/ml

0.32

111

1381

Insulin, combination of fast acting with intermediate-acting or long-acting

292

3847

0.69

8.91

1.1

1.20

1.85

u/ml

1.03

160

1980

Other enthesopathies

286

1954

1.47

8.86

1.1

1.11

1.53

u/ml

0.64

142

894

Migraine without aura

345

2445

1.42

8.85

1.1

1.74

2.13

u/ml

0.28

177

1273

Later onset COPD, excluding more controls

100

3.02

8.74

1.0

0.28

0.27

u/ml

0.01

Peritonsillar abscess

215

1389

1.56

8.72

1.1

1.0

1.98

2.21

u/ml

0.16

105

605

Inflammatory diseases of female pelvic organs

765

4458

1.27

8.64

1.1

2.05

1.82

u/ml

0.26

379

2155

Type 2 diabetes, wide definition

371

3286

0.72

8.63

1.1

1.17

1.41

u/ml

0.35

196

1503

ILD, hospital admission 2, with pulmonary infections

204

2.52

8.62

1.1

0.92

1.82

u/ml

0.69

106

Other diseases of urinary system

1120

5181

1.22

8.54

1.1

1.73

2.08

u/ml

0.65

559

2636

Other and unspecified tonsillitis

554

3562

1.32

8.50

1.1

1.87

2.26

u/ml

0.50

286

1847

Disorders of eyelid, lacrimal system and orbit

822

5004

1.25

8.43

1.1

1.84

1.83

u/ml

0.01

425

2475

Rosacea

126

718

1.77

8.40

1.1

1.14

1.37

u/ml

0.33

320

Other menopausal disorders

259

970

1.51

8.38

1.1

1.0

0.96

1.35

u/ml

0.55

114

429

Emphysema

3.39

8.34

1.2

1.0

3.48

1.84

u/ml

0.37

Other and unspecified vaccines and biological substances

4.65

8.31

1.2

1.1

2.63

2.93

u/ml

0.04

Alcohol dependence

1547

0.51

8.30

1.1

0.65

1.74

u/ml

3.52

742

346

4214

0.72

8.29

1.1

2.30

1.81

u/ml

0.40

203

2060

Alcohol use disorder, Swedish definition

274

3610

0.69

8.26

1.1

2.06

1.77

u/ml

0.20

162

1739

Unspecified threat to breathing

3.65

8.26

1.1

2.08

2.65

u/ml

0.11

Cerebrovascular diseases

250

2577

0.68

8.24

1.1

0.86

1.21

u/ml

0.53

118

1232

Vasomotor rhinitis (mode)

357

2.10

8.15

1.1

1.25

1.87

u/ml

0.33

184

Arthropathies

1294

5490

1.20

8.12

1.1

1.82

2.32

u/ml

1.13

674

2826

319

4020

0.71

8.08

1.1

2.45

1.83

u/ml

0.49

188

1979

953

4713

1.23

7.96

1.1

2.35

1.83

u/ml

0.76

544

2281

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

953

4713

1.23

7.96

1.1

2.35

1.83

u/ml

0.76

544

2281

Disease of hard tissues of teeth, NOS

530

2104

1.32

7.93

1.1

1.23

1.82

u/ml

1.30

263

978

Restless leg syndrome

122

701

1.76

7.92

1.1

1.45

1.41

u/ml

0.02

332

Chondrocostal junction syndrome [Tietze]

196

2.50

7.87

1.1

1.51

2.11

u/ml

0.25

101

Diseases of external ear

332

2385

1.40

7.87

1.1

1.84

2.23

u/ml

0.41

191

1249

Otitis externa

254

1740

1.47

7.86

1.1

2.21

1.90

u/ml

0.23

143

905

Hyperkinetic disorders, excluding more controls

283

1897

1.45

7.85

1.1

2.44

3.14

u/ml

0.56

180

1049

Mental and behavioural disorders due to psychoactive substance use

366

4602

0.73

7.83

1.1

2.43

1.74

u/ml

0.67

215

2260

Generalized anxiety disorder

274

1909

1.45

7.81

1.1

1.91

2.45

u/ml

0.42

166

949

Heart failure, not strict

303

2878

0.71

7.64

1.1

0.80

1.52

u/ml

2.37

156

1415

Other viral diseases, not elsewhere classified

406

3017

1.35

7.58

1.1

2.36

2.41

u/ml

0.03

205

1671

Dipeptidyl peptidase 4 (DPP-4) inhibitors

137

1789

0.61

7.57

1.0

1.1

0.83

1.22

u/ml

0.61

829

Periodontitis

615

5204

0.79

7.57

1.1

1.89

1.64

u/ml

0.25

320

2455

Cervicocranial syndrome

107

601

1.80

7.53

1.1

1.31

1.57

u/ml

0.16

283

Substance abuse

349

4452

0.73

7.52

1.1

2.47

1.75

u/ml

0.67

207

2189

Chronic periodontitis, including avohilmo

613

5194

0.79

7.49

1.1

1.89

1.63

u/ml

0.27

320

2449

Transport accidents

562

3773

1.29

7.45

1.1

1.95

2.16

u/ml

0.20

285

1825

Unspecified acute lower respiratory infection

163

1029

1.60

7.41

1.1

2.15

2.02

u/ml

0.06

102

518

Unspecified mental disorder

262

3704

0.70

7.34

1.1

0.92

1.89

u/ml

3.78

157

1832

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

244

1684

1.46

7.34

1.1

3.00

1.74

u/ml

0.89

120

828

Injuries to the ankle and foot

930

6837

1.21

7.32

1.1

2.37

2.13

u/ml

0.32

528

3454

Oedema, not elsewhere classified

252

1727

1.45

7.23

1.1

1.22

1.67

u/ml

0.72

135

832

Subjective visual disturbances

244

1687

1.46

7.22

1.1

1.83

1.70

u/ml

0.10

143

844

Factors influencing health status and contact with health services

340

1226

1.40

7.21

1.1

2.16

2.56

u/ml

0.32

188

519

Otalgia

113

656

1.75

7.17

1.2

1.1

2.40

2.14

u/ml

0.07

378

Mental and behavioural disorders due to alcohol

280

3744

0.72

7.09

1.1

2.60

1.89

u/ml

0.52

167

1838

Migraine without aura and triptan purchases

269

1904

1.43

7.08

1.1

1.83

u/ml

0.00

130

986

Other diseases of oesophagus

322

2.07

7.08

1.1

0.97

1.36

u/ml

0.33

166

Fibromyalgia

115

674

1.73

7.04

1.1

1.21

1.73

u/ml

0.58

301

Other and unspecified drugs and medicaments

499

1.85

6.98

1.1

1.20

1.80

u/ml

0.47

247

Unspecified privation

114

668

1.72

6.97

1.1

1.79

1.67

u/ml

0.07

327

COPD, hospital admission 2, with asthma infections

135

703

1.65

6.97

1.1

1.0

1.33

1.16

u/ml

0.16

342

COPD related to multimorbidity

150

791

1.61

6.92

1.1

1.0

1.82

0.93

u/ml

1.08

370

Pain in thoracic spine

163

1047

1.57

6.91

1.1

1.56

1.59

u/ml

0.02

491

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

210

2.34

6.84

1.0

1.1

0.94

1.51

u/ml

0.48

Injury, poisoning and certain other consequences of external causes

731

2953

1.25

6.82

1.1

1.81

2.09

u/ml

0.41

388

1437

COPD, hospital admissions 1, only main diagnosis

141

746

1.62

6.81

1.0

1.1

1.90

1.10

u/ml

0.87

365

Other diseases of lip and oral mucosa

370

2771

1.34

6.81

1.1

2.07

1.79

u/ml

0.21

205

1377

Stroke, including SAH

174

1907

0.66

6.79

1.1

1.08

1.23

u/ml

0.13

924

Urticaria due to cold and heat

3.74

6.71

1.3

1.0

3.19

2.79

u/ml

0.07

Organic, including symptomatic, mental disorders

1025

0.55

6.68

1.0

0.39

1.00

u/ml

2.43

511

Disturbance of activity and attention

286

2030

1.40

6.67

1.1

2.65

2.74

u/ml

0.05

182

1208

Psychiatric diseases

1121

4730

1.19

6.65

1.1

1.69

2.16

u/ml

1.12

588

2340

Diaphragmatic hernia

213

1461

1.46

6.58

1.1

1.51

1.07

u/ml

0.39

113

680

Other/unspecified dorsalgia

355

2634

1.34

6.57

1.1

0.82

1.77

u/ml

4.04

215

1271

GASTRO-related operations

1162

4935

1.18

6.54

1.1

1.97

2.40

u/ml

0.69

607

2563

Any gastric operation

1162

4935

1.18

6.54

1.1

1.97

2.40

u/ml

0.69

607

2563

Hypertrophy of breast in women and men

220

1524

1.45

6.52

1.1

1.78

1.55

u/ml

0.15

107

708

Unspecified chronic bronchitis

3.67

6.48

1.3

1.0

3.07

2.40

u/ml

0.09

Pain in limb

926

5168

1.20

6.46

1.1

1.72

2.21

u/ml

0.97

470

2624

Substance abuse, excluding more controls

349

3946

0.75

6.44

1.1

2.47

1.95

u/ml

0.42

207

1863

Insulin, intermediate and long-acting

260

3497

0.72

6.44

1.0

1.1

1.29

1.85

u/ml

0.72

144

1797

STROKE

272

2553

0.72

6.44

1.1

1.04

1.39

u/ml

0.51

138

1189

Allergic contact dermatitis due to drugs in contact with skin

102

2.91

6.42

1.0

2.62

1.46

u/ml

0.30

Dermatophytosis

607

4883

1.25

6.36

1.1

1.76

1.90

u/ml

0.13

288

2442

Visual disturbances

454

3536

1.29

6.32

1.1

1.76

2.04

u/ml

0.37

265

1834

Oesophagitis

198

2.30

6.30

1.1

0.74

1.62

u/ml

0.75

102

Striking against or struck by other objects

423

3268

1.30

6.26

1.1

2.43

2.32

u/ml

0.07

229

1777

Selective deficiency of immunoglobulin G [IgG] subclasses

6.02

6.25

1.1

1.0

5.95

1.25

u/ml

—

Acute and transient psychotic disorders

923

0.46

6.25

1.1

0.80

1.84

u/ml

1.31

444

Dental pulpitis, including avohilmo

1151

6372

1.18

6.22

1.1

1.65

2.10

u/ml

0.96

596

3112

Other degenerative diseases of the nervous system

934

0.53

6.21

1.1

0.86

1.17

u/ml

0.21

423

Inflammatory diseases of prostate (prostatitis)

459

1.82

6.21

1.1

1.0

2.31

1.77

u/ml

0.15

229

Polyarthropathies

476

3954

0.78

6.20

1.1

1.07

2.02

u/ml

3.46

245

1946

Malignant neoplasm of breast, ER-positive, including Hilmo

126

1536

0.63

6.19

1.1

1.85

1.09

u/ml

0.51

690

Hyperkinetic disorders

298

2159

1.37

6.12

1.1

2.63

2.70

u/ml

0.04

193

1286

Other nutritional deficiencies

757

5894

1.21

6.11

1.1

1.64

2.00

u/ml

0.59

415

2871

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

361

2743

1.32

6.10

1.1

2.82

1.94

u/ml

0.48

205

1407

Malignant neoplasm of breast, HER-positive

122

1504

0.63

6.03

1.1

1.88

1.00

u/ml

0.61

676

General examination and investigation of persons without complaint and reported diagnosis

697

2961

1.23

6.02

1.1

1.94

2.20

u/ml

0.30

375

1335

Diarrhoea and gastroenteritis of presumed infectious origin

825

6204

1.20

5.99

1.1

1.76

2.20

u/ml

0.69

457

3180

Dislocation, sprain and strain of joints and ligaments of knee

723

5497

1.22

5.98

1.1

1.81

1.90

u/ml

0.11

371

2671

Persons encountering health services in other circumstances

463

3630

1.27

5.91

1.1

2.03

2.31

u/ml

0.27

218

1865

Internal derangement of knee

366

2784

1.31

5.90

1.1

1.69

1.70

u/ml

0.01

176

1317

Benign neoplasm: Colon, unspecified

115

708

1.63

5.86

1.1

1.88

1.10

u/ml

0.43

334

Nonalcoholic fatty liver disease

101

603

1.69

5.85

1.1

1.84

1.75

u/ml

0.03

289

Condition for Implicit Sepsis (Organ dysfunction codes)

571

4980

0.81

5.84

1.1

1.90

1.82

u/ml

0.09

295

2516

Stroke, excluding SAH

153

1675

0.66

5.83

1.1

1.10

1.27

u/ml

0.13

806

Septicaemia

152

2125

0.67

5.82

1.1

2.40

1.99

u/ml

0.22

1131

Dermatitis due to substances taken internally

313

1.97

5.80

1.0

1.1

5.99

0.96

u/ml

1.33

144

Dyshidrosis [pompholyx]

2.86

5.80

1.0

1.1

0.72

1.10

u/ml

0.38

Infections of the skin and subcutaneous tissue

658

5350

1.22

5.79

1.1

1.95

2.10

u/ml

0.18

383

2764

Excessive attrition of teeth

663

5451

1.22

5.78

1.1

1.83

2.03

u/ml

0.21

348

2690

Panic disorder

237

1705

1.40

5.77

1.1

1.61

2.14

u/ml

0.77

139

833

Acute tubulo-interstitial nephritis

376

4191

0.77

5.76

1.1

1.52

1.89

u/ml

0.48

212

2149

Herpesviral [herpes simplex] infections

126

800

1.59

5.72

1.1

4.38

1.49

u/ml

1.26

402

Female infertility, cervical, vaginal, other or unspecified origin

375

1868

1.31

5.67

1.1

1.86

2.08

u/ml

0.26

182

912

Other and unspecified polyneuropathies, also in other diseases

101

608

1.67

5.64

1.1

1.91

1.34

u/ml

0.27

294

Visual disturbances and blindness

473

3759

1.26

5.62

1.1

1.75

2.05

u/ml

0.43

277

1962

Erysipelas

378

3716

0.77

5.60

1.1

2.28

1.48

u/ml

1.08

217

1760

Acute laryngitis and tracheitis

219

1539

1.41

5.58

1.2

1.1

2.49

2.74

u/ml

0.13

133

867

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

455

3211

1.27

5.55

1.1

2.49

2.94

u/ml

0.45

277

1823

Occupational exposure to risk-factors

141

2.45

5.49

1.1

1.0

0.39

1.50

u/ml

1.41

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

772

0.46

5.41

1.0

0.57

1.17

u/ml

0.68

362

Hypertrophy of breast

198

1397

1.43

5.40

1.1

1.83

1.46

u/ml

0.24

643

Acute appendicitis, no complications

642

5274

1.22

5.40

1.1

2.14

1.82

u/ml

0.32

302

2547

Tinnitus

182

1264

1.45

5.39

1.1

1.50

1.32

u/ml

0.11

600

Postviral fatigue syndrome

2.93

5.27

1.3

1.0

0.77

1.36

u/ml

0.36

Sub-endpoint used in defining T1D endpoints

181

2521

0.70

5.26

1.1

1.41

2.28

u/ml

0.88

104

1357

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

659

4317

1.21

5.26

1.1

1.75

1.68

u/ml

0.06

291

2056

Autoimmune diseases excluding thyroid diseases

963

6143

0.85

5.24

1.1

1.46

2.34

u/ml

2.74

532

3144

Lichen simplex chronicus

132

2.46

5.23

1.1

1.99

0.80

u/ml

0.46

Other extrapyramidal and movement disorders in other diseases

168

1156

1.46

5.23

1.1

1.99

1.40

u/ml

0.50

563

Any operation in hilmo

202

1.87

5.20

1.1

1.0

2.55

3.10

u/ml

0.15

Schizoaffective disorder

653

0.42

5.16

1.1

1.14

1.67

u/ml

0.52

315

Viral pneumonia

124

805

1.55

5.14

1.1

2.61

1.77

u/ml

0.33

426

Diseases of oral cavity, salivary glands and jaws

529

2190

1.25

5.14

1.1

1.44

1.91

u/ml

0.77

277

1045

Mental retardation, wide definition

586

0.40

5.10

1.2

2.47

2.86

u/ml

0.06

398

Speech therapy

192

1362

1.42

5.08

1.1

0.69

1.57

u/ml

2.62

122

667

Viral and other specified intestinal infections

454

3512

1.25

5.08

1.1

3.08

2.64

u/ml

0.24

255

1950

Exclusions for E4_PCOS_CONSORTIUM

694

5196

0.83

5.07

1.1

1.72

2.16

u/ml

0.67

326

2657

Disorders of muscles

604

1.64

5.07

1.1

0.95

1.79

u/ml

0.92

278

Other diseases of the respiratory system

103

642

1.61

5.06

1.1

1.50

1.53

u/ml

0.02

351

Other respiratory disorders and diseases

103

642

1.61

5.06

1.1

1.50

1.53

u/ml

0.02

351

Endometriosis of pelvic peritoneum

201

1372

1.41

5.04

1.1

0.79

1.85

u/ml

2.67

666

Autoimmune diseases excluding thyroid diseases, strict definition

946

6043

0.86

5.03

1.1

1.48

2.33

u/ml

2.53

522

3100

Liquid cancers, helper endpoint

120

1590

0.66

5.03

1.1

1.88

1.31

u/ml

0.31

811

Injury of muscle and tendon at shoulder and upper arm level

212

1533

1.39

5.01

1.1

1.69

1.32

u/ml

0.16

106

712

Other disorders of patella

200

1434

1.40

5.01

1.1

1.20

1.37

u/ml

0.17

667

Other disorders of white blood cells

253

2.00

5.00

1.2

1.1

2.60

2.37

u/ml

0.05

135

Other contact dermatitis

455

1.73

4.98

1.1

3.61

1.05

u/ml

1.14

191

Appendicitis, broad definition

791

6060

1.18

4.97

1.1

2.16

1.76

u/ml

0.51

372

2930

Candidiasis

133

885

1.51

4.94

1.1

1.99

1.50

u/ml

0.20

447

Hypermobility syndrome

564

1.66

4.94

1.1

1.16

1.66

u/ml

0.47

275

Type 1 diabetes

183

2550

0.71

4.93

1.1

1.41

2.27

u/ml

0.88

105

1373

Diseases of appendix

794

6069

1.18

4.92

1.1

2.15

1.75

u/ml

0.51

373

2936

Noninfective enteritis and colitis

498

4051

1.23

4.84

1.1

2.49

2.19

u/ml

0.27

286

2141

Mental retardation

571

0.41

4.83

1.2

2.47

2.88

u/ml

0.06

392

Transplanted organ and tissue status

676

0.45

4.81

1.0

1.1

0.37

1.87

u/ml

5.62

379

Adenomyosis (Endometriosis of uterus)

113

731

1.56

4.79

1.1

1.06

1.11

u/ml

0.04

332

Ischaemic Stroke, excluding all haemorrhages

137

1494

0.68

4.74

1.1

1.18

1.23

u/ml

0.03

715

Metabolic disorders

689

4998

0.84

4.73

1.1

1.31

1.91

u/ml

1.77

384

2442

Benign neoplasm: Liver/bile ducts

152

2.28

4.70

1.0

1.1

0.32

1.32

u/ml

1.64

Disorders of breast

516

3837

1.22

4.70

1.1

1.76

1.69

u/ml

0.06

263

1804

Sulfonylureas

569

0.47

4.67

1.0

2.45

0.91

u/ml

0.71

279

Dysplasia of cervi uteri

315

1760

1.30

4.67

1.1

1.92

1.87

u/ml

0.03

141

848

Disorders of the thyroid gland

989

5563

1.16

4.67

1.1

1.45

1.93

u/ml

0.97

462

2797

Other disorders of breast

134

906

1.49

4.65

1.1

1.32

1.41

u/ml

0.05

428

Epiphora

2.95

4.63

1.1

1.0

0.31

1.80

u/ml

—

Female infertility

404

1950

1.26

4.60

1.1

1.66

2.06

u/ml

0.59

197

966

Malignant neoplasm of digestive organs

1019

0.61

4.60

1.0

1.75

1.18

u/ml

0.34

501

Hard cardiovascular diseases

516

3746

0.82

4.59

1.1

1.27

1.70

u/ml

0.85

242

1858

Postmenopausal atrophic vaginitis

167

639

1.45

4.58

1.1

1.0

0.28

1.26

u/ml

2.47

283

Injuries to the knee and lower leg

1346

6591

1.14

4.56

1.1

1.72

2.17

u/ml

1.04

702

3326

Dislocation, sprain and strain of joints and ligaments at neck level

206

1511

1.37

4.56

1.1

2.96

1.97

u/ml

0.57

108

754

Implicit Sepsis

432

4025

0.81

4.56

1.1

1.85

1.82

u/ml

0.03

232

2035

Disorders of sclera, cornea, iris and ciliary body

522

4301

1.22

4.56

1.1

2.64

1.78

u/ml

1.03

275

2150

Type 1 diabetes, wide definition

166

2317

0.71

4.56

1.1

1.77

2.29

u/ml

0.35

1249

Excessive, frequent and irregular menstruation

511

2283

1.23

4.55

1.1

1.91

2.44

u/ml

0.53

255

1189

228

0.22

4.54

1.0

1.1

—

1.46

—

114

Other diseases of stomach and duodenum

207

2.05

4.53

1.1

1.0

4.03

1.66

u/ml

0.46

109

Acute appendicitis

748

5952

1.18

4.49

1.1

2.02

1.77

u/ml

0.28

354

2880

Olecranon bursitis

208

2.04

4.48

1.0

1.1

2.15

1.76

u/ml

0.13

Anomalies of dental arch relationship, including avohilmo

314

2208

1.29

4.47

1.1

1.69

2.88

u/ml

1.77

172

1249

Suppurative otitis media, unspecified

209

2.05

4.47

1.0

1.1

1.39

1.85

u/ml

0.31

125

Dialysis, with operation codes

657

0.47

4.46

1.0

1.1

0.61

1.59

u/ml

2.73

363

Benign neoplasm: Liver

137

2.31

4.42

1.0

1.1

0.35

1.41

u/ml

1.52

Ovarian cyst

433

2009

1.25

4.42

1.1

1.35

2.08

u/ml

1.45

234

1004

Irregular menses

655

4359

1.19

4.39

1.1

1.56

2.07

u/ml

0.72

320

2104

Infections with a predominantly sexual mode of transmission

605

4726

1.20

4.39

1.1

2.21

2.35

u/ml

0.11

294

2398

ILD, hospital admissions 3, with pneumonia sepsis

176

2.11

4.38

1.1

0.39

0.82

u/ml

0.73

Myotonic disorders

4.10

4.36

1.3

1.1

2.63

2.39

u/ml

—

Cervicalgia

166

1183

1.41

4.35

1.1

1.65

1.36

u/ml

0.18

552

Other otitis externa (chronic)

406

1.72

4.33

1.0

1.1

2.99

2.13

u/ml

0.25

222

Ganglion

223

1669

1.34

4.33

1.1

1.52

1.74

u/ml

0.18

115

782

Other reaction to severe stress, and adjustment disorders

486

4002

1.22

4.32

1.1

2.12

2.09

u/ml

0.02

269

1940

Type 1 diabetes, wide definition, subgroup 1

161

2235

0.72

4.30

1.1

1.53

2.23

u/ml

0.56

1201

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

765

0.52

4.30

1.1

2.22

2.41

u/ml

0.09

392

Bacterial Sepsis

159

1898

0.71

4.29

1.0

1.1

1.40

1.54

u/ml

0.14

975

Other septicaemia

134

1850

0.69

4.29

1.1

2.31

1.86

u/ml

0.23

978

Cerebrovascular diseases (FINNGEN)

180

1746

0.73

4.28

1.1

1.13

1.43

u/ml

0.28

806

Ocular pain

642

1.56

4.23

1.1

0.99

1.66

u/ml

0.83

321

Other disorders of eye and adnexa

158

1124

1.42

4.23

1.1

1.61

1.66

u/ml

0.03

574

Drug-induced adrenocortical insufficiency

103

2.48

4.18

1.2

1.1

0.61

0.76

u/ml

0.12

Disorders of thyroid, IBD co-morbidities

224

1178

1.34

4.16

1.1

2.26

2.01

u/ml

0.14

108

597

Inflammatory disease of uterus

185

1356

1.37

4.16

1.2

1.1

2.23

1.54

u/ml

0.52

646

Diseases of male genital organs

480

1979

1.23

4.15

1.1

1.42

2.50

u/ml

2.45

252

1101

Diseases of salivary glands

293

2291

1.28

4.14

1.1

1.42

1.89

u/ml

0.38

146

1131

Dementia, including avohilmo

580

0.54

4.14

1.0

0.16

0.74

u/ml

2.56

304

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

599

3193

1.20

4.14

1.1

2.05

2.08

u/ml

0.03

298

1540

Acute renal failure

693

0.50

4.14

1.0

1.1

0.74

1.35

u/ml

0.89

350

Peripheral artery disease

901

0.61

4.13

1.1

1.0

0.21

0.91

u/ml

3.79

443

Flat foot [pes planus] (acquired)

519

1.61

4.13

1.1

0.71

1.81

u/ml

1.98

255

Impetigo

529

1.61

4.13

1.2

1.1

4.45

2.24

u/ml

0.81

314

L04AD Calcineurin inhibitors

896

0.56

4.10

1.0

1.1

3.73

1.81

u/ml

0.62

502

Explicit Sepsis

199

2484

0.75

4.10

1.1

2.02

1.94

u/ml

0.04

121

1308

Toxic effect of contact with venomous animals

287

1.84

4.10

1.0

1.1

1.79

1.70

u/ml

0.03

152

Radiculopathy

646

1.54

4.09

1.2

1.1

1.44

1.35

u/ml

0.03

287

Noninflammatory disorders of female genital tract

571

2388

1.20

4.08

1.1

1.76

2.51

u/ml

1.17

290

1263

Other neurological diseases

343

3367

0.80

4.08

1.1

1.07

1.57

u/ml

1.01

186

1649

Mental and behavioural disorders due to opioids

393

0.35

4.06

1.0

1.1

0.19

1.86

u/ml

—

198

Other diseases of liver

153

1091

1.41

4.04

1.1

2.42

1.71

u/ml

0.26

519

Covid-19 suspected case

287

2248

1.28

4.04

1.1

1.70

2.02

u/ml

0.27

169

1145

Seborrhoeic dermatitis

430

1.66

4.02

1.1

3.40

0.83

u/ml

0.48

200

Congenital malformations, deformations and chromosomal abnormalities

828

6611

1.16

4.01

1.1

2.16

2.21

u/ml

0.05

443

3377

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

304

1.81

4.01

1.1

2.01

1.85

u/ml

0.06

161

Peroneal tendinitis

2.58

4.00

1.0

0.50

2.28

u/ml

1.14

Hypothyreosis and Thyroxine purchase for inclusion criteria

952

5448

1.15

4.00

1.1

1.39

1.93

u/ml

1.23

433

2736

Extrapyramidal and movement disorders

223

1689

1.32

4.00

1.1

1.89

1.25

u/ml

0.74

110

818

Atypical facial pain

275

1.84

3.98

1.1

0.61

1.70

u/ml

1.57

141

Vulvovaginal ulceration/inflammation in other diseases

605

1.56

3.97

1.1

2.13

1.53

u/ml

0.16

290

Mental retardation, excluding more controls

514

0.45

3.97

1.2

2.47

2.61

u/ml

0.02

351

Condition for Implicit Sepsis (Organ dysfunction codes)

699

5623

0.85

3.96

1.1

1.80

1.94

u/ml

0.18

357

2850

Pulmonary eosinophilia, not elsewhere classified

4.54

3.96

1.2

1.0

0.45

0.36

u/ml

—

Nonsuppurative otitis media

388

2726

1.24

3.95

1.1

2.39

2.95

u/ml

0.47

238

1537

Keratitis

337

2698

1.25

3.94

1.1

3.17

1.78

u/ml

1.41

182

1324

Hypothyroidism, other/unspecified

922

5287

1.15

3.92

1.1

1.43

1.93

u/ml

1.09

421

2657

COPD-related respiratory insufficiency

212

1.94

3.90

1.1

1.0

1.64

1.08

u/ml

0.23

105

Subacute thyroiditis

206

1.97

3.89

1.0

2.65

1.23

u/ml

0.24

Recurrent aphthous stomatitis , including avohilmo

146

1041

1.41

3.89

1.1

2.51

2.16

u/ml

0.07

572

Degenerative diseases of the nervous system

381

0.44

3.88

1.1

0.23

0.79

u/ml

1.72

204

Nephropathy related operations

646

0.51

3.82

1.0

1.1

0.51

1.49

u/ml

2.98

355

Insulin, fast-acting

215

2807

0.76

3.82

1.1

1.39

2.06

u/ml

0.69

114

1481

Disorders of tooth development and eruption

221

1360

1.32

3.81

1.1

1.85

2.38

u/ml

0.31

104

696

Insulin, fast-acting or short human

215

2806

0.76

3.80

1.1

1.39

2.05

u/ml

0.69

114

1481

Implicit Sepsis

542

4699

0.84

3.80

1.1

1.99

1.79

u/ml

0.23

278

2376

Other bacterial intestinal infections

179

1324

1.36

3.80

1.1

0.75

1.97

u/ml

3.61

671

Valvular heart disease excluding rheumatic fever

181

1755

0.74

3.80

1.0

1.1

1.17

1.75

u/ml

0.67

914

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

578

0.48

3.79

1.0

1.39

1.26

u/ml

—

269

All influenza

236

1818

1.30

3.78

1.1

2.52

1.95

u/ml

0.25

130

989

Alzheimer disease, including avohilmo

312

0.41

3.78

1.1

1.0

0.31

0.37

u/ml

0.14

168

Other disorders of urethra and urinary system

667

4115

1.17

3.77

1.1

2.04

1.81

u/ml

0.21

330

2035

Type 1 diabetes, strict (exclude DM2)

1430

0.67

3.77

1.1

1.91

2.68

u/ml

0.39

814

Any dementia, excluding more controls

419

0.49

3.77

1.0

0.24

0.78

u/ml

1.64

216

Deep bite

202

1336

1.34

3.77

1.1

3.03

3.11

u/ml

0.03

119

850

Unspecific neurodegenerative disorder

416

0.49

3.76

1.1

1.0

0.27

0.47

u/ml

0.62

227

Obesity

689

5715

1.17

3.76

1.1

1.45

2.02

u/ml

1.18

380

2764

Hypothyroidism, strict autoimmune

795

4527

1.16

3.76

1.1

1.47

2.03

u/ml

1.08

364

2241

Chronic kidney disease

993

0.61

3.74

1.0

1.1

1.49

1.57

u/ml

0.04

519

Other disorders of bone

212

1614

1.32

3.73

1.1

1.95

2.04

u/ml

0.04

115

815

Trigger finger

111

759

1.47

3.71

1.1

1.36

1.59

u/ml

0.14

341

Obesity and other hyperalimentation

690

5723

1.16

3.71

1.1

1.45

2.02

u/ml

1.20

381

2770

Other obstetric conditions, not elsewhere classified

600

3240

1.18

3.70

1.1

2.12

2.07

u/ml

0.04

298

1555

Mycoses

224

1720

1.31

3.69

1.1

1.65

1.58

u/ml

0.04

111

865

Genitourinary diseases

767

3316

1.16

3.68

1.1

1.72

2.70

u/ml

2.57

413

1826

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

261

1.83

3.68

1.0

1.1

3.12

1.45

u/ml

0.49

152

Spinal osteochondrosis

2.93

3.66

1.1

1.68

2.76

u/ml

0.30

Dementia

523

0.55

3.66

1.0

0.18

0.69

u/ml

2.30

276

Rotator cuff syndrome

432

2556

1.21

3.66

1.0

1.1

1.01

1.43

u/ml

0.77

206

1132

Gluteal tendinitis

176

2.01

3.65

1.0

1.1

0.77

0.78

u/ml

0.00

Benign neoplasm: Choroid

197

1.94

3.63

1.1

1.0

1.41

1.40

u/ml

0.00

Other systemic involvement of connective tissue

197

1492

1.33

3.59

1.1

0.74

1.47

u/ml

2.08

102

729

Otitis externa, unspecified

126

890

1.43

3.58

1.1

2.35

2.07

u/ml

0.12

471

ILD-related respiratory insufficiency

2.97

3.58

1.1

4.39

1.77

u/ml

—

Other enthesopathy of foot (+metatarsalgia)

627

1.51

3.58

1.1

1.66

1.71

u/ml

0.02

287

Rheumatism, unspecified

651

1.50

3.57

1.1

1.30

1.50

u/ml

0.09

291

Symptoms and signs involving the nervous and musculoskeletal systems

515

4344

1.19

3.57

1.1

1.78

1.94

u/ml

0.15

283

2240

Other disorders of eyelid

210

1527

1.31

3.57

1.1

1.82

1.20

u/ml

0.35

102

721

Other diseases of intestines

1286

6547

1.12

3.56

1.1

1.79

2.24

u/ml

0.86

636

3386

Lichen ruber planus, wide definition including periferal and oral lichen planus

140

1008

1.39

3.54

1.1

1.59

1.31

u/ml

0.16

468

Stomatitis and related lesions

209

1601

1.31

3.54

1.1

2.71

2.01

u/ml

0.24

110

836

Heart failure, strict

134

1313

0.72

3.52

1.1

0.92

1.09

u/ml

0.18

670

Suicide or other Intentional self-harm

177

2344

0.75

3.52

1.1

1.83

2.16

u/ml

0.21

100

1183

Unspecified event, undetermined intent

179

1.99

3.52

1.2

1.1

2.39

2.27

u/ml

0.03

Lumbar disc prolapse

574

3744

1.18

3.52

1.1

1.49

1.66

u/ml

0.20

296

1728

Endometriosis

387

1855

1.23

3.52

1.1

1.00

2.01

u/ml

2.14

176

914

Other intervertebral disc disorders

780

4078

1.15

3.51

1.1

1.38

1.70

u/ml

0.58

388

1889

Type 1 diabetes, definitions combined

1432

0.68

3.51

1.1

2.33

2.65

u/ml

0.12

814

Other disorders of adrenal gland

332

1.71

3.51

1.2

1.1

0.74

2.62

u/ml

2.53

191

Malaise and fatigue

435

2908

1.21

3.51

1.1

0.94

2.03

u/ml

5.08

248

1493

Superficial injury of hip and thigh

104

711

1.47

3.49

1.1

2.31

1.70

u/ml

0.28

363

Single spontaneous delivery

305

2012

0.80

3.48

1.1

1.63

2.33

u/ml

1.04

171

1074

Type 1 diabetes, strict definition, subgroup 1

1250

0.66

3.47

1.1

2.14

2.69

u/ml

0.22

715

Any dementia

419

0.51

3.46

1.0

0.23

0.67

u/ml

1.46

223

Abnormal findings in secretions and smears from cervix uteri vagina vulva

617

3997

1.17

3.45

1.1

1.79

1.71

u/ml

0.07

278

1891

Covid-19 confirmed case

293

2348

1.25

3.44

1.1

2.39

1.87

u/ml

0.32

155

1211

Lateral epicondylitis

116

813

1.43

3.44

1.1

0.82

1.56

u/ml

1.07

353

Heart failure,strict

131

1283

0.72

3.44

1.1

0.96

1.13

u/ml

0.17

649

Other specified/unspecified soft tissue disorders

173

1.98

3.44

1.1

1.0

2.30

1.85

u/ml

0.12

Other disorders of penis

633

1.50

3.43

1.1

1.91

3.01

u/ml

0.59

379

Substance use, excluding alcohol

133

1829

0.72

3.42

1.1

2.79

2.14

u/ml

0.28

912

Disorders of lipoprotein metabolism and other lipidaemias

452

3344

0.84

3.42

1.1

0.87

1.39

u/ml

1.65

251

1555

Other systemic involvement of connective tissue (FG)

194

1459

1.32

3.41

1.1

0.75

1.34

u/ml

1.51

700

Hypertensive diseases

657

4297

0.86

3.38

1.1

1.38

1.66

u/ml

0.46

337

2055

Redundant prepuce, phimosis and paraphimosis

194

1466

1.32

3.38

1.1

1.41

2.80

u/ml

2.48

110

794

Non-rheumatic valve diseases

177

1688

0.75

3.38

1.0

1.1

1.19

1.56

u/ml

0.37

865

All-cause Heart Failure

132

1287

0.72

3.37

1.1

1.0

0.76

1.10

u/ml

0.46

655

Crossbite

157

1077

1.37

3.37

1.2

1.1

1.59

3.43

u/ml

3.13

111

706

Lichen planus, including avohilmo

118

833

1.42

3.37

1.1

1.87

1.34

u/ml

0.27

376

Disorders of orbit

239

1.82

3.36

1.0

1.1

0.96

2.20

u/ml

0.95

126

Cervicobrachial syndrome

189

1439

1.32

3.36

1.1

1.37

1.46

u/ml

0.05

101

660

Separation of retinal layers (serosa)

196

1.91

3.35

1.1

0.43

1.90

u/ml

2.33

Combinations of oral blood glucose lowering drugs

1093

0.65

3.35

1.0

2.33

1.26

u/ml

0.36

501

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

864

6384

0.88

3.35

1.1

1.87

2.10

u/ml

0.27

449

3245

Benign neoplasm of other and ill-defined parts of digestive system

103

710

1.46

3.34

1.1

0.73

1.40

u/ml

1.10

339

Type 1 diabetes, strict definition

1310

0.68

3.34

1.1

2.49

2.67

u/ml

0.06

755

Adrenocortical insufficiency

226

1.84

3.31

1.2

1.1

0.65

1.56

u/ml

1.24

122

Hypertension

657

4288

0.86

3.31

1.1

1.38

1.67

u/ml

0.47

337

2051

Insulin, fast-acting (human)

1325

0.68

3.29

1.0

1.1

1.10

2.04

u/ml

1.26

659

Diseases of arteries, arterioles and capillaries

235

2203

0.79

3.28

1.1

1.48

1.26

u/ml

0.12

116

1068

Shoulder lesions

623

3243

1.17

3.27

1.1

0.91

1.54

u/ml

2.11

300

1481

Other specified disorders of external ear

109

2.22

3.26

1.0

4.49

2.14

u/ml

0.31

123

805

1.40

3.25

1.1

1.0

0.81

0.93

u/ml

0.09

401

Immunodeficiency with predominantly antibody defects

192

1.91

3.23

1.1

2.53

2.41

u/ml

0.02

111

Appendectomy

709

5914

1.15

3.23

1.1

1.88

1.81

u/ml

0.08

349

2857

Other and specified injuries of hip and thigh

2.47

3.23

1.1

1.0

1.07

3.30

u/ml

0.71

Thyroiditis

481

1.55

3.22

1.1

2.66

1.41

u/ml

0.44

236

Disorders of choroid and retina

405

3445

0.83

3.21

1.1

0.84

1.50

u/ml

2.15

199

1658

Otitis media, unspecified

207

1481

1.30

3.20

1.2

1.1

2.96

3.15

u/ml

0.08

134

894

Postpartum care and examination

176

1460

0.76

3.19

1.1

2.79

2.62

u/ml

0.08

720

Presence of cardiac and vascular implants and grafts

1046

0.69

3.19

1.0

0.77

1.06

u/ml

0.34

532

Dental operations

517

2248

1.18

3.19

1.1

1.25

1.54

u/ml

0.58

256

1058

Erysipelas

246

2730

0.80

3.18

1.1

2.17

1.35

u/ml

1.11

145

1301

Complications predominantly related to the puerperium

323

2646

1.23

3.16

1.1

1.76

1.69

u/ml

0.04

157

1265

Spondylolisthesis/Spondylolysis

128

928

1.39

3.16

1.1

0.57

1.47

u/ml

2.50

421

Nausea and vomiting

249

1941

1.26

3.15

1.1

1.26

2.47

u/ml

2.46

145

1118

Metatarsalgia

572

1.50

3.15

1.1

1.75

1.66

u/ml

0.04

263

Other specified/unspecified bacterial intestinal infections

304

1.69

3.15

1.1

0.65

1.98

u/ml

1.78

160

Injury of muscle and tendon at lower leg level

120

863

1.40

3.12

1.1

0.67

2.00

u/ml

3.14

422

Mental and behavioural disorders due to use of other stimulants, including caffeine

330

0.39

3.12

1.2

1.1

10.12

2.05

u/ml

—

171

Urethritis and urethral syndrome

105

2.22

3.11

1.3

1.0

1.66

1.91

u/ml

0.06

Immunodeficiencies

344

1.65

3.11

1.1

1.92

2.13

u/ml

0.05

194

Disorders of eyelid in diseases classified elsewhere

166

1.95

3.11

1.2

1.0

6.31

2.25

u/ml

0.59

Endometriosis of rectovaginal septum and vagina

454

1.55

3.09

1.1

0.85

1.06

u/ml

0.22

204

Certain infectious and parasitic diseases

1181

5312

1.12

3.09

1.1

2.25

2.15

u/ml

0.12

625

2658

Ischemic heart diseases

488

3444

0.85

3.08

1.1

1.31

1.73

u/ml

0.79

218

1714

Coronary artery bypass grafting

371

0.50

3.06

1.0

0.27

0.86

u/ml

1.85

181

Other viral hepatitis

584

0.54

3.06

1.2

1.1

0.53

2.05

u/ml

2.93

277

Polyp of the female genital tract

271

1245

1.25

3.06

1.1

2.22

1.49

u/ml

0.50

130

581

Other/unspecified synovitis and tenosynovitis

666

1.45

3.06

1.0

1.1

0.90

1.76

u/ml

0.84

309

Sequelae of other external causes

292

1.69

3.04

1.1

0.60

1.73

u/ml

1.50

152

Benign neoplasm: Ascending colon

369

1.61

3.02

1.1

2.54

1.15

u/ml

0.40

186

All influenza (not pneumonia)

156

1176

1.33

3.02

1.1

3.20

2.00

u/ml

0.38

633

Other demyelinating diseases of the central nervous system

340

0.41

3.02

1.1

0.28

1.81

u/ml

—

155

Acute lymphadenitis

546

1.50

3.02

1.1

1.32

2.16

u/ml

0.58

283

Menorrhagia

346

1578

1.22

3.02

1.1

1.67

1.80

u/ml

0.10

169

759

Other and unspecified disorders of vitreous body

204

1572

1.28

3.00

1.1

1.07

1.08

u/ml

0.01

103

716

Polyneuropathies and other disorders of the peripheral nervous system

114

818

1.40

3.00

1.1

1.71

1.36

u/ml

0.17

402

Falls/tendency to fall

1330

6030

1.11

2.99

1.1

1.99

2.13

u/ml

0.19

714

3005

Atherosclerosis, excluding cerebral and coronary sclerosis

721

0.64

2.99

1.1

1.0

0.24

0.93

u/ml

2.72

363

Hypothyroidism and >3 levothyroxin purchases

445

2121

1.19

2.99

1.1

1.88

2.63

u/ml

0.75

217

1070

Hypothyroidism, levothyroxine purchases

445

2121

1.19

2.99

1.1

1.88

2.63

u/ml

0.75

217

1070

Other immunodeficiencies

2.34

2.98

1.1

0.81

1.59

u/ml

0.34

Acne

197

1537

1.29

2.98

1.1

3.05

2.73

u/ml

0.14

129

860

Benign neoplasm of eye and adnexa

418

1.56

2.98

1.0

1.1

1.28

1.82

u/ml

0.30

213

Lichen planus

490

1.52

2.97

1.1

2.11

1.43

u/ml

0.24

236

Other bursopathies

572

1.48

2.95

1.1

2.76

1.78

u/ml

0.27

260

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

566

0.55

2.95

1.1

0.75

1.49

u/ml

0.51

282

Contact urticaria

4.33

2.94

1.1

1.0

4.84

3.55

u/ml

—

Benign neoplasm of middle ear and respiratory system

295

1.67

2.93

1.1

0.99

1.75

u/ml

0.51

153

Benign neoplasm: Colon

248

1899

1.25

2.93

1.1

1.12

1.06

u/ml

0.05

130

884

Chondropathies

161

1226

1.32

2.93

1.1

2.37

1.97

u/ml

0.15

620

Use of disulfiram, acamprosate or naltrexone

602

0.56

2.92

1.0

1.1

0.65

2.01

u/ml

2.42

280

Haemangioma, any site

525

1.50

2.92

1.2

1.1

0.86

1.83

u/ml

1.68

284

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

156

1.94

2.91

1.0

0.55

2.63

u/ml

1.96

Other and unspecified trigeminal disorders

2.47

2.90

1.1

1.0

2.17

1.34

u/ml

—

Viral warts

262

2122

1.24

2.90

1.1

2.55

2.39

u/ml

0.08

114

1141

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

2.63

2.89

1.3

1.0

0.31

2.35

u/ml

—

Haemangioma and lymphangioma, any site

600

1.46

2.89

1.1

0.98

1.74

u/ml

1.25

320

Hypothyroidism (congenital or acquired)

449

2148

1.19

2.88

1.1

1.83

2.60

u/ml

0.80

221

1086

Embedded and impacted teeth

490

3467

1.17

2.87

1.1

2.54

2.64

u/ml

0.06

272

1890

Heart failure and coronary heart disease

810

0.68

2.87

1.1

1.0

1.33

0.86

u/ml

0.32

422

Iron deficiency

306

1.66

2.87

1.1

0.17

1.97

u/ml

5.82

160

Nonorganic sleeping disorders, excluding more controls

237

1901

1.25

2.86

1.1

1.76

2.27

u/ml

0.37

128

935

Coeliac disease

128

946

1.36

2.86

1.1

1.69

2.08

u/ml

0.21

508

Sciatica+with lumbago

444

3476

1.18

2.86

1.1

1.56

1.64

u/ml

0.07

245

1602

L02BG Aromatase inhibitors

1310

0.71

2.85

1.1

1.20

1.23

u/ml

0.02

610

Open wound of wrist and hand

468

3913

1.17

2.85

1.1

2.79

1.84

u/ml

0.94

240

1969

Demyelinating diseases of the central nervous system

759

0.61

2.85

1.0

1.1

1.25

1.42

u/ml

0.06

366

Other complications of surgical and medical care, not elsewhere classified

602

1.45

2.84

1.1

1.37

1.85

u/ml

0.33

290

Implicit bacterial Sepsis

125

1492

0.74

2.84

1.0

1.1

1.01

1.34

u/ml

0.59

740

Faecal incontinence

298

1.65

2.83

1.1

1.0

0.20

1.75

u/ml

2.46

154

Abrasion of teeth

287

2352

1.22

2.83

1.1

1.01

1.29

u/ml

0.48

141

1115

Acute alcohol intoxication, ICD10

115

1564

0.73

2.83

1.1

2.90

2.17

u/ml

0.29

794

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

208

1.79

2.82

1.0

1.46

0.96

u/ml

0.31

105

Care involving use of rehabilitation procedures

580

4638

1.15

2.81

1.1

1.71

1.94

u/ml

0.20

347

2262

Certain disorders involving the immune mechanism

162

1242

1.31

2.81

1.1

2.42

1.59

u/ml

0.34

621

MS-disease / Multiple Sclerosis

657

0.59

2.81

1.0

1.1

1.56

1.46

u/ml

0.03

324

Mental and behavioural disorders due to cannabinoids

383

0.46

2.81

1.2

1.1

0.82

2.12

u/ml

1.56

202

Chronic periodontitis, complicated

242

2963

0.81

2.80

1.0

1.1

1.31

1.42

u/ml

0.10

131

1372

Benign neoplasm: Duodenum

2.57

2.79

1.2

1.0

0.69

0.47

u/ml

—

Tramadol

730

3949

1.14

2.79

1.1

1.08

1.83

u/ml

1.88

382

1860

Atrial septal defect

497

0.53

2.78

1.0

1.2

3.35

3.32

u/ml

0.00

347

Major coronary heart disease event excluding revascularizations

184

1568

0.78

2.78

1.1

1.0

1.24

1.12

u/ml

0.11

746

Bacterial infection, other or unspecified

285

2928

0.82

2.77

1.1

1.99

1.58

u/ml

0.37

162

1490

Superficial injury of wrist and hand

256

2080

1.24

2.77

1.1

1.74

2.11

u/ml

0.29

135

1106

Viral hepatitis

629

0.58

2.77

1.1

0.50

2.05

u/ml

3.31

303

malignant neoplasm of male genital organs

554

0.65

2.77

1.0

1.1

0.70

1.02

u/ml

0.40

266

Other symptoms and signs involving the nervous and musculoskeletal systems

385

3251

1.19

2.76

1.1

1.68

1.90

u/ml

0.18

209

1664

Abscess of external ear

2.41

2.75

1.0

1.1

4.31

2.56

u/ml

—

Polyuria

126

935

1.35

2.74

1.1

0.74

1.33

u/ml

1.16

455

Pre-eclampsia or poor fetal growth

289

3482

0.82

2.74

1.1

1.85

u/ml

0.00

133

1654

Pure hypercholesterolaemia

363

2819

0.84

2.74

1.1

0.81

1.25

u/ml

1.14

208

1292

Blepharochalasis

120

884

1.36

2.73

1.1

1.0

0.40

0.90

u/ml

1.91

409

Acute alcohol intoxication

132

1749

0.75

2.73

1.1

2.77

2.00

u/ml

0.36

862

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

430

3629

1.18

2.72

1.1

2.07

2.23

u/ml

0.15

249

1940

Reimbursement for rheumatic diseases

366

4315

0.84

2.72

1.1

1.20

1.87

u/ml

1.30

191

2153

Short Achilles tendon (acquired)

132

1.99

2.72

1.1

1.0

4.83

2.43

u/ml

0.22

Emergency coronary revascularization (for ACS)

453

3217

0.85

2.71

1.1

1.16

1.73

u/ml

1.24

197

1604

Use of anticholinesterases

323

0.49

2.71

1.1

1.0

0.24

0.37

u/ml

—

170

N06DA Anticholinesterases

323

0.49

2.71

1.1

1.0

0.24

0.37

u/ml

—

170

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

131

1734

0.75

2.71

1.1

2.20

2.16

u/ml

0.02

871

Struck by thrown, projected or falling objec

381

1.56

2.71

1.1

2.30

2.05

u/ml

0.05

202

Fissure and fistula of anal and rectal regions

197

1557

1.27

2.71

1.1

2.36

1.65

u/ml

0.30

764

Alcoholic liver disease

339

0.44

2.71

1.1

1.0

0.22

1.24

u/ml

—

166

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

145

1087

1.33

2.71

1.2

1.1

3.41

2.49

u/ml

0.33

676

Sequelae of cerebrovascular disease

909

0.68

2.70

1.0

1.1

0.46

1.03

u/ml

1.53

430

Cervical disc disorders

236

1906

1.24

2.68

1.1

2.38

1.40

u/ml

0.53

116

843

Post-traumatic stress disorder

139

1053

1.33

2.68

1.1

2.24

2.12

u/ml

0.05

542

Uterine polyps

478

1.49

2.68

1.0

2.86

1.25

u/ml

0.53

215

Other local infections of skin and subcutaneous tissue

635

1.43

2.67

1.1

1.36

1.96

u/ml

0.52

324

Contracture of joint

2.83

2.66

1.0

2.25

3.44

u/ml

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

320

1.61

2.65

1.0

1.1

0.50

2.28

u/ml

3.03

151

Continuous positive airway pressure

162

1053

1.30

2.64

1.1

0.83

2.12

u/ml

3.18

548

Stenosis and insufficiency of lacrimal passages

423

1.52

2.64

1.1

2.24

1.65

u/ml

0.26

213

Other viral diseases

397

3370

1.18

2.62

1.1

2.04

2.56

u/ml

0.46

210

1867

Carpal tunnel syndrome

484

3682

1.16

2.62

1.1

1.68

1.39

u/ml

0.31

220

1713

Thyroiditis, ILD-related definition

126

944

1.34

2.61

1.0

1.1

1.11

1.79

u/ml

0.80

463

Other/unspecified enthesopathies, not elsewhere classified

368

1.56

2.61

1.2

1.1

0.70

2.20

u/ml

2.00

168

Other acute skin changes due to ultraviolet radiation

127

1.99

2.61

1.1

1.0

0.48

1.63

u/ml

1.27

Disorders of gallbladder, biliary tract and pancreas

698

4972

0.88

2.61

1.1

0.91

1.68

u/ml

4.45

327

2372

L04AA Selective immunosuppressants

134

1758

0.76

2.60

1.1

1.60

1.88

u/ml

0.22

893

Mild mental retardation

275

0.39

2.60

1.2

1.1

7.02

2.35

u/ml

—

175

Umbilical hernia

206

1646

1.26

2.60

1.1

2.45

1.35

u/ml

0.79

112

805

Pain, not elsewhere classified

272

2241

1.22

2.58

1.1

1.38

2.13

u/ml

1.29

155

1113

Viral haemorrhagic fevers, not elsewhere classified/unspecified

141

1075

1.32

2.57

1.1

2.89

1.60

u/ml

0.74

573

Other shoulder lesions

624

1.42

2.56

1.1

1.31

1.72

u/ml

0.36

284

Contusion of toe(s) with damage to nail

2.32

2.54

1.1

0.76

0.92

u/ml

—

Budesonide

126

948

1.34

2.54

1.1

2.06

1.44

u/ml

0.35

435

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

801

6174

0.89

2.53

1.1

1.84

1.93

u/ml

0.09

449

3089

Other/unspecified enthesopathies of lower limb, excluding foot

460

1.49

2.53

1.1

1.16

1.48

u/ml

0.17

210

Patellar tendinitis

129

1.97

2.53

1.0

1.1

5.24

3.08

u/ml

0.35

Retinal breaks without detachment

625

1.41

2.52

1.1

0.79

1.31

u/ml

0.73

296

Delivery

322

2029

0.83

2.52

1.1

1.55

2.32

u/ml

1.27

177

1082

Chronic mastoiditis

2.29

2.52

1.1

1.0

0.78

0.84

u/ml

—

Major coronary heart disease event

471

3288

0.86

2.51

1.1

1.14

1.73

u/ml

1.39

208

1636

Unspecified/other endometriosis

130

986

1.33

2.50

1.1

1.29

1.85

u/ml

0.38

484

Noninfectious colitis NAS

131

994

1.32

2.50

1.2

1.1

2.05

1.83

u/ml

0.09

526

Atrial septal defect, secundum type

403

0.51

2.50

1.0

1.2

3.56

3.23

u/ml

0.04

283

Oter anti-inflammatory and antirheumatic agents, non-steroids

106

423

1.39

2.49

1.1

1.22

1.48

u/ml

0.10

216

Other puerperal infections

133

1014

1.32

2.49

1.1

3.49

1.58

u/ml

0.87

491

Other disorders of cornea

470

1.48

2.48

1.1

5.60

1.79

u/ml

1.37

224

Coronary atherosclerosis

232

1803

0.81

2.48

1.0

1.1

1.50

1.19

u/ml

0.33

110

842

Maternal care for other known or suspected fetal problems

316

2382

0.84

2.48

1.1

2.27

2.10

u/ml

0.10

148

1194

Impingement syndrome of shoulder

144

1108

1.30

2.47

1.0

1.1

0.58

1.17

u/ml

1.61

492

Superficial injury of lower leg

256

2108

1.22

2.47

1.1

1.90

2.40

u/ml

0.47

136

1098

Bacterial infection, other or unspecified

242

2558

0.82

2.47

1.1

2.19

1.50

u/ml

0.61

133

1306

Pericarditis

137

1.91

2.46

1.2

1.0

1.15

1.99

u/ml

0.43

Other and unspecified local infections of skin and subcutaneous tissue

612

1.41

2.46

1.1

1.43

1.98

u/ml

0.45

312

Glaucoma suspect

172

1355

1.27

2.46

1.1

1.85

1.22

u/ml

0.27

660

Injuries to the neck

251

2065

1.22

2.45

1.1

2.69

2.19

u/ml

0.29

130

1050

Other spirochaetal diseases

226

1839

1.23

2.44

1.1

1.35

1.42

u/ml

0.05

107

902

Localized swelling, mass and lump of skin and subcutaneous tissue

257

2119

1.22

2.44

1.1

0.93

1.64

u/ml

1.69

135

1067

Use of pramipexole

117

876

1.34

2.44

1.1

0.96

1.37

u/ml

0.34

414

Status post-ami

427

0.59

2.43

1.0

0.89

0.78

u/ml

0.05

201

Fitting and adjustment of other devices

156

1096

1.29

2.42

1.1

0.41

1.37

u/ml

3.52

510

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

507

4408

1.15

2.42

1.1

2.72

2.29

u/ml

0.39

273

2300

Other predominantly sexually transmitted diseases, not elsewhere classified

310

2609

1.19

2.40

1.1

2.83

2.24

u/ml

0.32

152

1331

Single delivery by caesarean section

229

1608

0.81

2.39

1.1

2.23

2.13

u/ml

0.05

847

Abnormal involuntary movements

106

786

1.35

2.38

1.1

2.04

1.91

u/ml

0.07

392

Fracture of femur

703

0.66

2.37

1.0

1.1

2.56

1.51

u/ml

0.41

376

Defects in the complement system

2.39

2.36

1.1

0.26

0.78

u/ml

—

Medicines for HER+ breast cancer

154

1855

0.78

2.36

1.1

1.96

1.11

u/ml

0.68

840

Arthropod-borne viral fevers and viral haemorrhagic fevers

153

1196

1.28

2.35

1.1

2.66

1.69

u/ml

0.56

635

Bleeding

493

4015

0.87

2.35

1.1

2.69

1.75

u/ml

0.71

268

2009

Chronic apical periodontitis

1015

6358

0.91

2.34

1.1

1.80

1.90

u/ml

0.12

508

3125

Other noninflammatory disorders of vagina

485

1.45

2.34

1.0

1.1

0.54

1.28

u/ml

1.61

221

Presence of other devices

107

793

1.35

2.34

1.1

0.28

1.41

u/ml

4.85

381

Obsessive-compulsive disorder

117

886

1.33

2.32

1.1

2.27

2.21

u/ml

0.04

474

Malignant neoplasm of respiratory system and intrathoracic organs

375

0.55

2.32

1.0

1.1

0.06

1.28

u/ml

3.00

187

Chronic viral hepatitis

498

0.58

2.32

1.1

0.55

1.88

u/ml

2.92

234

Complications associated with artificial fertilization

185

1.76

2.31

1.0

1.1

2.91

1.38

u/ml

0.54

Sacrococcygeal disorders, not elsewhere classified

177

1.77

2.31

1.1

0.14

2.00

u/ml

3.34

Erosion of teeth , including avohilmo

303

2554

1.19

2.31

1.1

2.15

2.21

u/ml

0.03

168

1306

Diseases of arteries, arterioles and capillaries (FINNGEN)

105

972

0.75

2.31

1.1

0.81

1.31

u/ml

0.76

442

Type1 diabetes, definitions combined, early onset

1136

0.72

2.31

1.1

2.28

2.72

u/ml

0.15

680

Other abnormal products of conception

493

2847

1.15

2.30

1.1

2.55

1.92

u/ml

0.59

223

1346

Coronary revascularization (ANGIO or CABG)

446

3147

0.87

2.30

1.1

1.18

1.75

u/ml

1.23

194

1565

Idiopathic pulmonary fibrosis

119

1.94

2.30

1.0

1.54

1.02

u/ml

0.16

Secondary uncertain malignant neoplasm

422

0.54

2.30

1.1

1.12

1.49

u/ml

—

224

Anogenital herpesviral [herpes simplex] infection

158

1248

1.27

2.28

1.1

1.34

1.94

u/ml

0.64

631

Other spirochaetal diseases

230

1892

1.22

2.27

1.1

1.32

1.43

u/ml

0.08

110

932

Other erythematous conditions

156

1.81

2.26

1.1

0.67

1.84

u/ml

1.09

Percutaneous Coronary Intervention

446

3145

0.87

2.25

1.1

1.18

1.75

u/ml

1.23

194

1565

Persons encountering health services in circumstances related to reproduction

727

4383

1.12

2.25

1.1

2.52

2.42

u/ml

0.08

383

2314

Other skin changes

113

854

1.33

2.25

1.1

3.49

1.45

u/ml

0.83

430

Deforming dorsopathies

248

2058

1.21

2.24

1.1

1.11

2.07

u/ml

2.31

130

1050

Congenital malformations, deformations and chromosomal abnormalities

747

6393

1.11

2.24

1.1

2.33

2.24

u/ml

0.09

400

3302

Leiomyoma of uterus

439

2865

0.87

2.23

1.1

1.25

1.36

u/ml

0.11

180

1308

Contraceptive management

504

3096

1.14

2.23

1.1

1.64

2.03

u/ml

0.48

238

1516

Hallux rigidus

473

1.44

2.23

1.1

1.0

0.86

1.18

u/ml

0.26

223

Perforation of tympanic membrane

650

1.38

2.22

1.1

0.76

2.03

u/ml

2.66

332

Other symptoms and signs involving the circulatory and respiratory systems

295

1.57

2.22

1.1

1.0

0.50

2.04

u/ml

2.28

147

Excessive earwax

387

3256

1.16

2.22

1.1

1.55

2.07

u/ml

0.48

217

1679

Pre-eclampsia

154

1938

0.79

2.21

1.1

2.62

1.33

u/ml

0.68

931

Heart failure and antihypertensive medication

823

0.74

2.21

1.1

1.19

1.76

u/ml

0.49

394

Other mycoses, not elsewhere classified/unspecified

2.16

2.20

1.0

5.64

2.45

u/ml

—

Other and unspecified visual disturbances

559

1.40

2.18

1.2

1.1

1.32

1.76

u/ml

0.31

279

Fever of other and unknown origin

536

4212

1.13

2.17

1.1

2.38

2.26

u/ml

0.08

299

2167

Lyme disease

219

1802

1.22

2.17

1.1

1.34

1.39

u/ml

0.03

106

875

Malignant neoplasm of skin

170

1453

0.80

2.17

1.1

0.74

0.96

u/ml

0.36

684

Disorders of other endocrine glands

440

3776

1.15

2.16

1.1

1.65

2.21

u/ml

0.75

252

2044

Hypertensive Heart Disease

453

0.62

2.16

1.0

0.16

1.15

u/ml

2.93

221

Other/unspecified soft tissue disorders related to use, overuse and pressure

159

1.78

2.15

1.1

1.0

0.33

3.09

u/ml

2.51

Viral pneumonia (unknown virus, not influenza)

436

1.45

2.15

1.1

3.17

1.82

u/ml

0.37

222

Intermittent heterotropia

775

0.68

2.14

1.1

4.39

2.97

u/ml

0.38

492

Neuralgia and neuritis, unspecified

251

1.60

2.13

1.1

1.18

2.55

u/ml

0.92

116

Systemic connective tissue disorders

240

1997

1.20

2.12

1.1

0.70

1.42

u/ml

2.73

126

969

Benign neoplasm: Scapula and long bones of upper limb

2.50

2.12

1.1

0.91

2.21

u/ml

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

485

1.39

2.12

1.1

1.0

1.17

1.16

u/ml

0.01

246

Crowding of teeth, including avohilmo

208

1412

1.23

2.12

1.1

3.24

3.52

u/ml

0.13

150

899

Dislocation, sprain and strain of joint and ligaments of hip

123

1.88

2.12

1.2

1.1

3.45

1.99

u/ml

0.27

Other bursitis of hip

2.23

2.12

1.1

1.0

0.85

2.13

u/ml

—

Other inflammation of vagina/vulva

348

1.51

2.11

1.0

1.03

1.47

u/ml

0.36

164

Rash and other nonspecific skin eruption

580

1.39

2.11

1.1

1.54

1.69

u/ml

0.08

306

Benign neoplasm: Small intestine

102

1.97

2.10

1.2

1.0

0.62

1.63

u/ml

0.48

Nontoxic goitre/thyroid nodule

168

1349

1.25

2.10

1.1

0.43

1.19

u/ml

2.78

638

Fracture at wrist and hand level

345

2959

1.17

2.10

1.1

2.75

2.06

u/ml

0.63

195

1540

Implicit bacterial Sepsis

153

1655

0.80

2.09

1.1

1.03

1.30

u/ml

0.44

833

Gingivitis and periodontal diseases

1051

4957

1.10

2.08

1.1

1.75

1.92

u/ml

0.27

551

2466

Pre-eclampsia or eclampsia

163

2022

0.80

2.08

1.1

2.44

1.31

u/ml

0.62

969

Disorders of lacrimal system and orbit in diseases classified elsewhere

124

1.88

2.08

1.0

0.75

1.44

u/ml

0.39

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

263

0.45

2.08

1.0

1.1

1.03

1.38

u/ml

—

128

Other and unspecified injuries of ankle and foot

415

1.46

2.08

1.1

0.83

2.13

u/ml

1.99

227

Other diseases of intestine

522

1.40

2.08

1.1

1.81

1.43

u/ml

0.15

267

Hypertensive heart and/or renal disease

527

0.66

2.08

1.0

0.19

1.09

u/ml

3.05

257

Other and unspecified erythematous conditions

146

1.80

2.07

1.1

0.34

1.72

u/ml

1.64

Streptococcal septicaemia

420

0.57

2.07

1.0

1.1

2.51

2.02

u/ml

0.11

244

Other benign neoplasms of uterus

103

1.95

2.05

1.1

1.0

1.68

0.40

u/ml

—

Spirochaetal infections, other/unspecified

220

1823

1.21

2.05

1.1

1.34

1.43

u/ml

0.06

106

888

Malignant neoplasm of bronchus and lung, including Hilmo

383

0.59

2.04

1.1

1.11

1.12

u/ml

0.01

194

Other symptoms and signs involving the digestive system and abdomen

127

991

1.29

2.03

1.1

0.52

1.69

u/ml

4.25

537

Implicit viral Sepsis

204

1679

1.22

2.03

1.1

1.70

1.76

u/ml

0.04

114

869

Cellulitis

197

1617

1.22

2.03

1.1

2.45

1.90

u/ml

0.26

110

833

Sequelae of injuries, of poisoning and of other consequences of external causes

204

1681

1.22

2.02

1.1

1.13

1.80

u/ml

1.16

103

832

Other gastritis (incl. Duodenitis)

119

922

1.29

2.01

1.1

1.57

1.37

u/ml

0.18

431

Infections with a predominantly sexual mode of transmission

409

3570

1.15

2.00

1.1

2.00

2.08

u/ml

0.05

198

1777

malignant neoplasm of female genital organs

549

0.63

2.00

1.0

1.1

2.08

1.09

u/ml

0.34

256

Other bursitis of knee

2.17

2.00

1.1

1.0

0.23

2.26

u/ml

—

Injury of muscle and tendon at hip and thigh level

569

1.38

2.00

1.1

1.48

1.53

u/ml

0.02

273

Other congenital malformations of skin

707

1.34

1.99

1.1

0.86

2.20

u/ml

2.68

379

Complications of medical and surgical care

612

5038

1.12

1.99

1.1

1.64

1.71

u/ml

0.07

318

2430

Actinic keratosis

628

1.34

1.99

1.1

1.0

0.96

0.77

u/ml

0.11

326

Melanocytic naevi

282

2398

1.18

1.99

1.1

2.27

1.80

u/ml

0.35

155

1211

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

428

3748

1.14

1.99

1.1

1.77

1.57

u/ml

0.15

220

1813

Asymmetry of jaw

134

1.83

1.98

1.1

1.05

2.53

u/ml

0.96

Obesity, other/unspecified

360

3121

1.16

1.98

1.1

1.69

1.81

u/ml

0.09

208

1518

Focal epilepsy, mode (most common among epilepsy diagnosis)

103

1340

0.77

1.98

1.1

3.06

2.32

u/ml

0.18

748

Malignant neoplasm of breast, ER-negative, including Hilmo

962

0.73

1.97

1.0

1.1

0.43

0.94

u/ml

1.53

447

Myocardial infarction, strict

123

1117

0.78

1.95

1.1

1.0

0.95

1.02

u/ml

0.06

525

Pulmonary heart disease

139

1103

1.26

1.95

1.1

0.97

1.29

u/ml

0.45

521

Pulmonary embolism

139

1103

1.26

1.95

1.1

0.97

1.29

u/ml

0.45

521

Cardiovascular diseases

1045

5156

1.09

1.94

1.1

2.29

2.40

u/ml

0.11

546

2706

Severe mental retardation

0.00

1.94

0.0

1.2

—

1.75

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

4.58

1.94

1.0

—

0.26

u/ml

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

825

5066

1.10

1.94

1.1

1.43

1.87

u/ml

0.79

374

2519

Other sleep disorders

676

1.34

1.92

1.1

2.43

1.79

u/ml

0.27

339

Finngen Rheumatological endpoints

951

5903

0.91

1.92

1.1

1.17

2.09

u/ml

4.20

502

2902

Persons encountering health services for specific procedures, not carried out

625

1.35

1.92

1.1

0.77

2.10

u/ml

3.08

292

Other retinal disorders

277

2531

0.85

1.92

1.1

0.57

1.48

u/ml

5.11

134

1253

Benign lipomatous neoplasm

189

1556

1.22

1.91

1.0

1.1

1.92

1.31

u/ml

0.28

742

Other disorders of veins

289

2457

1.17

1.91

1.1

1.06

1.30

u/ml

0.40

132

1136

Mental and behavioural disorders due to sedatives or hypnotics

556

0.64

1.90

1.1

1.55

2.11

u/ml

0.39

279

Endometriosis ASRM stages 1,2

202

1676

1.21

1.90

1.1

0.79

1.48

u/ml

1.72

795

Other infective otitis externa

340

1.48

1.90

1.1

2.09

2.11

u/ml

0.01

176

Synovial cyst of popliteal space [Baker]

259

1.55

1.89

1.1

1.0

3.54

2.17

u/ml

0.17

126

Sicca syndrome [Sjögren]

406

1.44

1.89

1.0

1.1

0.33

1.62

u/ml

2.87

196

Autoimmune thyroiditis

136

1.79

1.89

1.0

1.1

3.00

1.04

u/ml

0.56

Oxycodone

125

1429

0.79

1.89

1.1

1.0

0.62

1.31

u/ml

1.95

680

Symptoms and signs involving emotional state

260

1.56

1.88

1.1

1.31

2.48

u/ml

0.86

140

Disorders of ocular muscles, binocular movement, accommodation and refraction

546

4839

1.12

1.88

1.1

2.03

2.30

u/ml

0.29

289

2577

Inflammatory disorders of breast

603

1.35

1.86

1.1

3.23

1.43

u/ml

0.48

292

Ischaemic heart disease, wide definition

340

2430

0.87

1.86

1.1

1.35

1.20

u/ml

0.17

151

1114

Melanocytic naevi of other and unspecified parts of face

383

1.45

1.86

1.1

1.81

2.03

u/ml

0.06

197

Poisoning by drugs, medicaments and biological substances

207

2474

0.83

1.86

1.1

1.74

2.21

u/ml

0.60

122

1272

Explicit bacterial Sepsis

565

0.65

1.85

1.0

1.1

2.74

1.97

u/ml

0.22

308

Other superficial mycoses

124

980

1.27

1.84

1.1

2.09

1.92

u/ml

0.10

502

Primary_lymphoid and hematopoietic malignant neoplasms

963

0.74

1.84

1.1

2.30

1.45

u/ml

0.28

515

Ulcer of vagina/vulva

183

1.66

1.83

1.2

1.0

0.73

1.76

u/ml

1.07

Polyarteritis nodosa and related conditions

2.15

1.83

1.3

1.1

0.63

0.69

u/ml

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

281

3270

0.86

1.83

1.1

1.59

2.03

u/ml

0.45

149

1645

Acute epiglottitis

2.15

1.83

1.2

1.0

0.12

2.77

u/ml

—

Hypertensive diseases (excluding secondary)

542

3522

0.89

1.83

1.1

1.47

1.75

u/ml

0.38

283

1702

Nonorganic sleeping disorders

237

2004

1.19

1.82

1.1

1.76

2.14

u/ml

0.27

128

1022

Other acquired deformities of musculoskeletal system and connective tissue

238

1.57

1.82

1.1

3.15

1.50

u/ml

0.32

118

Fibroblastic disorders

115

901

1.28

1.82

1.1

1.70

1.48

u/ml

0.09

401

Malignant neoplasm of breast, HER-negative

818

0.72

1.81

1.1

0.34

0.94

u/ml

1.89

378

Myocardial infarction

139

1217

0.80

1.81

1.1

1.0

1.31

0.96

u/ml

0.33

572

Malignant neoplasm of bronchus and lung

294

0.56

1.81

1.0

1.1

0.07

1.35

u/ml

—

151

Other and unspecified acute skin changes due to ultraviolet radiation

2.28

1.81

1.1

1.0

0.41

1.46

u/ml

—

Adhesive capsulitis of shoulder

718

1.31

1.80

1.1

0.37

1.41

u/ml

3.16

313

Exposure to other and unspecified animate mechanical forces

304

1.50

1.80

1.1

1.70

2.10

u/ml

0.14

167

Autonomic disorders

116

1.83

1.79

1.0

1.1

0.18

2.16

u/ml

2.52

Postdysenteric arthropathy

2.38

1.79

1.2

1.0

0.88

3.09

u/ml

—

Viral infections characterized by skin and mucous membrane lesions

395

3472

1.14

1.79

1.1

2.91

2.10

u/ml

0.64

220

1845

Female infertility, tubal origin

378

1.44

1.79

1.1

1.18

1.04

u/ml

0.08

166

Retained placenta and membranes, without haemorrhage

116

913

1.28

1.79

1.1

0.86

1.34

u/ml

0.72

419

Fall on same level involving ice and snow

486

4334

1.12

1.77

1.1

1.90

1.92

u/ml

0.01

256

2173

Polyarthrosis

611

1.32

1.77

1.1

1.0

0.66

1.08

u/ml

0.62

283

Inflammation of lacrimal passages (acute and unspecified)

2.11

1.77

1.2

1.0

0.19

1.14

u/ml

—

Deep bite that required surgery

2.01

1.76

1.0

1.1

0.80

1.42

u/ml

—

Benign neoplasm: Transverse colon

288

1.50

1.76

1.1

1.0

0.21

1.24

u/ml

2.73

144

Tic disorders

202

1.62

1.76

1.2

2.46

2.85

u/ml

0.09

142

Tic and related disorders

210

1.61

1.75

1.2

2.57

2.04

u/ml

0.13

148

Special screening examination for neoplasms

185

1.63

1.75

1.0

0.05

0.76

u/ml

—

Endometriosis of ovary

156

1242

1.23

1.75

1.1

0.78

1.71

u/ml

2.22

592

Other congenital malformations of skin

372

1.44

1.75

1.1

1.14

2.72

u/ml

1.72

225

Viral pneumonia (known virus, not influenza)

132

1.76

1.75

1.1

3.57

2.60

u/ml

0.11

Other predominantly sexually transmitted diseases, not elsewhere classified

231

1959

1.18

1.74

1.1

2.53

2.05

u/ml

0.19

113

975

Focal epilepsy

127

1580

0.80

1.73

1.1

3.68

2.19

u/ml

0.44

876

156

1277

1.23

1.73

1.1

1.85

1.63

u/ml

0.11

597

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

155

1.69

1.73

1.1

0.20

2.61

u/ml

2.21

Other noninflammatory disorders of vulva and perineum

680

1.32

1.73

1.1

1.45

1.54

u/ml

0.05

330

Postpartum hemorraghe, parous women as controls

347

2582

1.15

1.73

1.1

1.49

1.85

u/ml

0.42

159

1202

LeFortI or BSSO operation

373

1.43

1.72

1.1

1.28

2.14

u/ml

0.66

184

Pedestrian injured in collision with pedal cycle

163

1.67

1.72

1.1

0.35

1.92

u/ml

2.35

Persistent delusional disorders

384

0.60

1.72

1.0

1.1

0.35

1.49

u/ml

3.01

183

Influenza and pneumonia

1162

6858

1.08

1.71

1.1

2.46

2.05

u/ml

0.57

657

3431

Acute otitis externa, noninfective

2.08

1.71

1.1

1.0

1.12

1.04

u/ml

—

Other deformities of toe(s)

118

1.79

1.70

1.0

1.1

0.95

1.99

u/ml

—

Impacted teeth

364

2845

1.14

1.70

1.1

2.58

2.89

u/ml

0.14

205

1577

ILD medications: immunosuppressive drugs

562

4703

1.11

1.70

1.1

2.72

1.90

u/ml

0.89

304

2272

Graves ophthalmopathy

126

1.76

1.69

1.0

0.75

1.43

u/ml

0.38

Malignant neoplasm of bladder

2.00

1.69

1.0

1.1

1.49

0.86

u/ml

—

Postpartum haemorrhage due to anatomy

159

1308

1.22

1.69

1.1

1.74

1.66

u/ml

0.04

612

Sequelae of injuries of upper limb

622

1.32

1.68

1.1

0.76

1.69

u/ml

1.60

306

Other disorders of conjunctiva

484

1.37

1.68

1.0

1.1

2.72

1.54

u/ml

0.55

241

Sequelae of external causes of morbidity and mortality

165

1361

1.22

1.68

1.1

1.60

1.48

u/ml

0.07

109

675

Skin changes due to chronic exposure to nonionizing radiation

693

1.29

1.67

1.1

1.0

0.92

0.90

u/ml

0.01

360

Parkinson's disease, including avohilmo

293

0.54

1.67

1.0

0.57

0.91

u/ml

—

154

Diagnoses used for exclusion with ILD

142

1154

1.23

1.67

1.1

2.22

1.54

u/ml

0.22

559

Other abnormal auditory perceptions

2.06

1.66

1.3

1.1

4.85

0.65

u/ml

—

Presence of other functional implants

204

1679

0.84

1.65

1.1

1.80

1.11

u/ml

0.42

814

Contact with machinery

520

1.35

1.65

1.1

3.03

1.77

u/ml

0.24

257

Concussion

574

4231

1.11

1.64

1.1

2.02

2.30

u/ml

0.31

319

2222

Other retinal artery occlusion

2.46

1.64

1.0

0.63

1.04

u/ml

—

Viral agents as the cause of diseases classified to other chapters

189

1.61

1.64

1.1

2.59

2.57

u/ml

0.01

105

Mixed specific developmental disorders

524

0.67

1.64

1.1

1.2

2.69

2.95

u/ml

0.08

384

Haemorrhage in early pregnancy

324

2759

1.15

1.63

1.1

1.28

1.84

u/ml

0.84

143

1317

severe traumatic brain injury, does not include concussion

828

0.74

1.63

1.1

1.03

1.49

u/ml

0.47

417

Biological medication for rheuma

140

1710

0.82

1.63

1.1

1.41

2.07

u/ml

0.56

860

Bicornuate uterus

2.12

1.62

1.0

1.1

0.10

1.20

u/ml

—

Atrial fibrillation and flutter

183

1419

0.83

1.62

1.0

1.1

2.14

1.54

u/ml

0.27

643

Intestinal malabsorption

278

1.49

1.62

1.1

4.52

1.91

u/ml

0.42

152

Perineal laceration during delivery

213

2094

0.85

1.62

1.1

2.02

2.31

u/ml

0.18

107

1021

Tic and related disorders

215

1.57

1.61

1.2

1.1

2.57

2.75

u/ml

0.04

151

Congenital absence, atresia and stenosis of large intestine

0.00

1.60

0.0

1.3

—

1.38

—

Varicose veins

282

2453

0.87

1.60

1.0

1.1

0.60

1.22

u/ml

2.20

114

1128

Mixed conductive and sensorineural hearing loss

429

1.38

1.60

1.1

1.0

1.68

1.40

u/ml

0.11

227

Any mental disorder

1166

5432

1.08

1.59

1.1

1.71

2.12

u/ml

0.96

645

2635

Benign neoplasm of mouth and pharynx

498

1.35

1.59

1.1

2.84

1.58

u/ml

0.49

248

Colonic or urogenital fistula

200

1691

1.19

1.58

1.1

2.32

1.50

u/ml

0.38

833

Pain associated with micturition

681

1.30

1.58

1.1

2.54

1.88

u/ml

0.26

358

Disorders of vitreous body

247

2051

1.16

1.57

1.1

1.10

1.14

u/ml

0.02

126

939

Other diseases of peritoneum

191

1.58

1.57

1.0

1.62

1.06

u/ml

0.25

Other and/or unspecified nontoxic goitre

338

1.43

1.57

1.0

0.41

1.49

u/ml

1.39

154

Foreign body in alimentary tract

330

1.43

1.56

1.1

0.96

2.18

u/ml

1.19

195

Other specified disorders of muscle

137

1.69

1.56

1.0

2.84

2.11

u/ml

0.14

Seropositive rheumatoid arthritis, strict definition

740

0.73

1.55

1.1

0.29

1.43

u/ml

4.07

342

Other arthrosis

363

2219

1.13

1.54

1.1

0.81

1.38

u/ml

1.34

187

990

Haemorrhoids and perianal venous thrombosis

180

1508

1.19

1.54

1.0

1.1

1.56

1.42

u/ml

0.09

737

Helminthiases

1.85

1.53

1.2

1.1

1.80

2.14

u/ml

—

Other diseases of anus and rectum

181

1519

1.19

1.52

1.1

1.63

1.54

u/ml

0.07

762

False labour

480

2688

1.12

1.52

1.1

1.63

2.15

u/ml

0.74

232

1322

Wide developmental disorders

663

0.71

1.52

1.1

1.2

0.99

3.10

u/ml

3.20

436

Care involving dialysis

371

0.62

1.52

1.0

1.1

0.45

1.83

u/ml

3.49

200

Trigeminal neuralgia

282

1.46

1.52

1.1

0.16

1.52

u/ml

3.47

140

Pregnancy, childbirth and the puerperium

252

1526

0.86

1.52

1.1

2.01

2.67

u/ml

0.68

138

819

Muscle strain

209

1.54

1.52

1.1

1.0

0.46

2.57

u/ml

3.18

106

Panniculitis affecting regions of neck and back

185

1.58

1.52

1.2

1.1

1.60

1.72

u/ml

0.03

Focal epilepsy, strict definition

112

1388

0.80

1.52

1.1

3.28

2.33

u/ml

0.25

777

Coxarthrosis [arthrosis of hip](FG)

218

1794

0.85

1.52

1.1

1.12

1.16

u/ml

0.03

802

Bursitis of shoulder

108

1.77

1.51

1.0

0.36

2.93

u/ml

1.91

Burn and corrosion confined to eye and adnexa

154

1.64

1.51

1.0

1.1

1.24

1.82

u/ml

—

Extracorporeal dialysis

270

0.55

1.51

1.0

1.1

0.53

1.46

u/ml

—

146

Delivery, wide proxy

286

1743

0.87

1.50

1.1

1.92

2.42

u/ml

0.56

155

931

Myocarditis

291

1.45

1.50

1.1

1.21

1.63

u/ml

0.31

135

Supervision of high-risk pregnancy

251

1746

0.86

1.50

1.1

1.64

2.41

u/ml

1.03

116

857

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

692

4833

0.92

1.49

1.1

1.14

1.60

u/ml

1.53

331

2275

Other/unspecified rheumatoid arthritis

417

0.65

1.48

1.2

1.1

0.83

1.58

u/ml

0.71

204

Unspecified fall

432

3818

1.12

1.48

1.1

2.31

2.26

u/ml

0.03

252

2062

Primary hyperparathyroidism

359

1.40

1.48

1.1

1.0

0.43

1.41

u/ml

1.47

180

Hypertension, essential

630

3906

0.91

1.47

1.1

1.42

1.61

u/ml

0.25

325

1782

Other congenital malformations

172

1447

1.19

1.47

1.1

2.00

2.39

u/ml

0.27

112

815

Oral lichen planus, including avohilmo , including avohilmo

276

1.46

1.47

1.0

1.1

0.14

1.39

u/ml

2.85

136

Meniscus derangement

420

2528

1.12

1.47

1.1

1.16

1.41

u/ml

0.39

207

1136

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

535

0.69

1.47

1.1

1.26

1.24

u/ml

0.01

266

Dystonia

318

1.42

1.46

1.1

1.85

2.03

u/ml

0.07

163

Retinal detachments and breaks

157

1310

1.20

1.46

1.1

1.35

1.24

u/ml

0.08

613

Habitual aborter

228

1.51

1.46

1.1

1.78

1.32

u/ml

0.14

Abnormal findings on diagnostic imaging of other body structures

628

1.29

1.45

1.1

1.67

1.40

u/ml

0.11

301

Unstable angina pectoris

767

0.77

1.45

1.1

1.0

0.58

0.99

u/ml

0.65

370

Ehlers-Danlos syndrome

1.83

1.45

1.0

1.90

2.02

u/ml

—

Poisoning by medicine

190

2229

0.85

1.45

1.1

1.74

2.19

u/ml

0.54

112

1145

Alopecia areata

204

1.54

1.44

1.0

1.1

3.13

1.91

u/ml

0.35

105

Use of hypnotics and sedatives

893

5527

0.93

1.44

1.1

1.24

1.80

u/ml

1.88

436

2664

Benign neoplasm: Other and unspecified parts of mouth

125

1.69

1.44

1.0

4.45

2.29

u/ml

—

Open wound of hip and thigh

253

1.48

1.44

1.1

0.67

2.20

u/ml

2.04

131

Other and unspecified follicular disorders

253

1.47

1.43

1.1

1.0

1.14

1.97

u/ml

0.69

126

Testicular hypofunction

180

1.57

1.43

1.1

3.46

2.47

u/ml

0.12

Spirochaetal infections, other/unspecified

413

1.36

1.42

1.1

1.18

1.82

u/ml

0.37

215

Bacterial intestinal infections, IBD co-morbidities

110

888

1.24

1.42

1.1

0.71

1.54

u/ml

1.93

436

Lymphoid leukaemia

226

0.53

1.42

1.2

0.17

1.63

u/ml

—

150

Parkinson's disease

277

0.58

1.41

1.0

0.57

0.95

u/ml

—

146

L04AC Interleukin inhibitors

482

0.68

1.41

1.0

1.1

1.13

1.84

u/ml

0.35

244

Obesity due to excess calories

478

4327

1.11

1.40

1.1

1.43

2.01

u/ml

1.03

260

2123

Disorders of vitreous body and globe

253

2115

1.15

1.40

1.1

1.07

1.19

u/ml

0.07

129

977

Toxic effects of substances chiefly nonmedicinal as to source

116

945

1.23

1.40

1.0

1.1

1.38

1.99

u/ml

0.60

496

Inflammatory disease of cervix uteri

271

1.45

1.39

1.1

1.0

1.06

1.05

u/ml

0.01

118

Bruxism

150

1.62

1.39

1.1

0.85

1.16

u/ml

—

Maternal care for other conditions predominantly related to pregnancy

301

2605

1.14

1.39

1.1

1.78

1.96

u/ml

0.10

136

1254

Pleural plaque

1.77

1.38

1.1

0.69

0.49

u/ml

—

Keratoconus

158

1.60

1.38

1.1

9.46

2.18

u/ml

1.21

Antihypertensive medication - note that there are other indications

999

4934

1.07

1.38

1.1

1.97

2.47

u/ml

0.94

509

2587

Cardiac murmurs and other cardiac sounds

105

838

1.24

1.38

1.1

3.10

2.71

u/ml

0.14

476

Monoamine oxidase A inhibitors

555

1.30

1.37

1.0

1.17

1.63

u/ml

0.36

259

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

453

4041

1.11

1.37

1.1

1.67

1.62

u/ml

0.04

234

1950

Speech and linguistic disorders, excluding more controls

150

1183

1.20

1.36

1.2

1.1

3.12

3.04

u/ml

0.02

104

741

Benign neoplasm: Skin of eyelid, including canthus

608

1.29

1.36

1.1

2.66

1.68

u/ml

0.43

286

Poor fetal growth

137

1641

0.83

1.36

1.1

1.63

1.59

u/ml

0.02

792

Unknown and unspecified causes of morbidity

408

1.35

1.36

1.1

0.36

1.73

u/ml

3.28

202

Pilonidal cyst

913

0.77

1.36

1.1

1.26

2.33

u/ml

1.22

440

Other protozoal intestinal diseases

167

1.57

1.35

1.1

1.12

1.94

u/ml

0.50

Non-selective monoamine reuptake inhibitors

225

1878

1.16

1.35

1.1

0.62

1.29

u/ml

2.72

129

844

SLE, ICD10

196

0.51

1.35

1.2

1.1

1.06

1.38

u/ml

—

101

SLE, strict definition

196

0.51

1.35

1.2

1.1

1.06

1.38

u/ml

—

101

Supplementary factors related to causes of morbidity and mortality classified elsewhere

290

2559

1.14

1.35

1.1

1.82

2.14

u/ml

0.34

172

1352

Emotional disorders starting during childhood or adolecense, excluding more controls

105

831

1.24

1.34

1.1

2.13

3.08

u/ml

0.42

534

593

0.72

1.34

1.2

4.95

3.23

u/ml

0.29

430

Congenital malformations of the urinary system

558

0.71

1.34

1.1

3.63

2.24

u/ml

0.42

340

Other disorders starting during childhood or adolecense, excluding more controls

114

894

1.23

1.34

1.1

3.45

2.76

u/ml

0.26

576

DVT of lower extremities and pulmonary embolism

201

1721

1.16

1.34

1.1

1.18

1.27

u/ml

0.10

100

827

670

0.74

1.34

1.2

4.39

3.65

u/ml

0.12

484

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

358

1.37

1.33

1.1

3.39

1.40

u/ml

0.38

180

Dermatitis herpetiformis

1.98

1.33

1.0

4.25

0.84

u/ml

—

Bilateral sagittal split ramus osteotomy operation

308

1.41

1.33

1.1

1.55

2.40

u/ml

0.51

148

Dental caries, including avohilmo

675

3172

1.09

1.33

1.1

1.42

1.93

u/ml

0.97

345

1515

Melanoma in situ

105

1.72

1.33

1.1

1.0

0.82

1.61

u/ml

—

Other and unspecified mononeuropathies of lower limb

113

1.69

1.32

1.0

0.46

1.89

u/ml

1.18

Certain conditions originating in the perinatal period

190

1447

1.17

1.32

1.2

1.1

5.32

3.04

u/ml

1.02

129

931

137

1144

1.20

1.31

1.1

1.89

2.01

u/ml

0.07

552

Testicular dysfunction

209

1.49

1.31

1.1

3.03

2.35

u/ml

0.09

100

Achilles tendinitis

533

1.30

1.31

1.1

3.95

1.30

u/ml

0.85

240

Open wound of abdomen, lower back and pelvis

234

1.47

1.30

1.2

1.1

0.86

2.46

u/ml

1.54

129

Other complications of labour and delivery, not elsewhere classified

155

1677

0.84

1.30

1.0

1.1

1.83

2.19

u/ml

0.23

810

Dislocation, sprain and strain of joints and ligaments of thorax

193

1.51

1.30

1.0

1.1

0.64

2.08

u/ml

1.49

Complications of procedures, not elsewhere classified

716

5479

1.08

1.30

1.1

1.76

u/ml

0.00

359

2633

Macular pucker

292

1.41

1.30

1.0

1.1

0.28

1.28

u/ml

1.51

148

Burns and corrosions confined to eye and internal organs

177

1.54

1.30

1.1

1.04

1.70

u/ml

0.34

Benign neoplasm: Skin of ear and external auricular canal

106

1.71

1.29

1.0

0.32

1.43

u/ml

—

Other and unspecified corneal deformities and disorders

169

1.55

1.29

1.0

1.1

1.85

1.81

u/ml

0.01

Puerperal sepsis

783

1.24

1.29

1.1

0.77

1.04

u/ml

0.31

355

Malignant neoplasm of prostate

438

0.75

1.29

1.0

0.77

0.99

u/ml

0.21

207

Fasciculation

1.96

1.29

1.0

0.20

0.76

u/ml

—

Examination and encounter for administrative purposes

161

1.56

1.29

1.1

1.0

0.56

1.88

u/ml

1.52

Periapical abscess

317

3554

0.89

1.28

1.1

2.03

1.73

u/ml

0.24

188

1761

Rheumatoid arthritis

155

1639

0.85

1.28

1.1

0.56

1.10

u/ml

1.98

741

Ptosis of eyelid

344

1.37

1.28

1.1

0.80

1.72

u/ml

1.12

178

Congenital malformations of cardiac septa

896

0.78

1.27

1.1

3.31

3.04

u/ml

0.08

593

Other disorders of the musculoskeletal system and connective tissue

659

1.26

1.27

1.1

1.77

1.62

u/ml

0.06

307

Congenital malformations of the urinary system

587

0.73

1.27

1.0

1.1

3.50

2.26

u/ml

0.38

352

Secondary and unspecified malignant neoplasm of lymph nodes

317

0.63

1.27

1.2

1.1

1.10

1.33

u/ml

—

166

Sarcoidosis

695

1.26

1.27

1.1

3.57

1.56

u/ml

0.43

314

Pulmonary heart disease, diseases of pulmonary circulation

146

1229

1.19

1.27

1.1

0.92

1.31

u/ml

0.60

596

Other congenital malformations of circulatory system

138

1.61

1.27

1.1

1.0

0.09

1.90

u/ml

—

Campylobacter enteritis

138

1.61

1.27

1.0

1.1

2.30

u/ml

—

Zoster [herpes zoster]

307

2688

1.13

1.26

1.1

1.37

1.66

u/ml

0.29

167

1317

Other or unspecified immunodeficiency

2.46

1.26

1.2

1.1

1.68

3.03

u/ml

—

Aplastic and other anaemias

163

1780

0.85

1.25

1.1

1.23

1.40

u/ml

0.16

907

Caries of dentine, including avohilmo

764

3616

1.08

1.25

1.1

1.69

2.06

u/ml

0.57

404

1769

SLE (Finngen)

216

0.55

1.25

1.2

1.1

1.06

1.33

u/ml

—

Dialysis

241

0.58

1.25

1.0

1.1

0.47

1.87

u/ml

—

145

Other bacterial intestinal infections

109

895

1.22

1.24

1.1

0.79

1.62

u/ml

1.63

456

Syncope and collapse

319

2436

1.12

1.24

1.1

1.92

2.12

u/ml

0.16

161

1247

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

432

3007

0.91

1.23

1.1

1.10

1.63

u/ml

1.35

202

1395

Cholecystectomy

514

4054

1.09

1.23

1.1

0.85

1.52

u/ml

3.39

240

1887

Viral conjunctivitis

330

1.37

1.23

1.1

0.52

1.98

u/ml

2.77

179

Placental disorders

1.75

1.23

1.0

1.72

1.68

u/ml

—

Disorders of refraction and accommodation

326

2907

1.12

1.23

1.1

2.26

2.44

u/ml

0.11

167

1621

Ehlers-Danlos syndrome

124

1.64

1.22

1.0

1.73

2.34

u/ml

0.19

Diseases of tongue

262

1.42

1.22

1.1

3.80

2.11

u/ml

0.46

115

Spondylosis

320

2328

1.12

1.22

1.1

1.46

1.34

u/ml

0.08

155

1029

Superficial injury of thorax

109

897

1.22

1.1

1.51

1.56

u/ml

0.03

450

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.74

1.22

1.1

3.36

2.76

u/ml

0.08

Use of biperiden

252

0.59

1.22

1.0

1.1

1.34

1.64

u/ml

—

124

Melanocytic naevi of lower limb, including hip

305

1.39

1.22

1.0

1.1

4.04

1.92

u/ml

0.40

155

Malignant neoplasm of corpus uteri, including Hilmo

252

0.59

1.21

1.1

1.0

1.80

1.13

u/ml

—

131

Benign neoplasm: Vulva

1.81

1.21

1.1

0.41

0.36

u/ml

—

Procedures for purposes other than remedying health state

124

1.63

1.21

1.1

1.0

3.74

0.96

u/ml

—

Other maternal disorders predominantly related to pregnancy

672

3896

1.08

1.21

1.1

1.53

2.07

u/ml

0.92

311

1883

Pulmonary artery stenosis

0.00

1.21

0.0

1.2

—

1.08

—

Mumps

140

1.58

1.21

1.1

1.0

2.95

2.05

u/ml

—

Hyperplasia of prostate

141

671

1.19

1.20

1.0

0.66

1.29

u/ml

0.98

312

Osteopathies and chondropathies

417

3524

1.10

1.20

1.1

1.62

1.88

u/ml

0.23

221

1778

Systemic lupus erythematosus

213

0.56

1.20

1.2

1.1

1.06

1.34

u/ml

—

110

Septal defects

854

0.79

1.20

1.1

1.2

3.53

3.02

u/ml

0.16

569

Medial epicondylitis

197

1.48

1.19

1.2

1.0

0.22

2.02

u/ml

2.52

Convergence insufficiency and excess

117

1.65

1.19

1.4

1.1

0.26

1.62

u/ml

2.05

Tumor necrosis factor alpha inhibitors

132

1564

0.84

1.19

1.1

1.49

2.09

u/ml

0.45

789

Oral lichen planus

1.76

1.19

1.0

0.12

0.95

u/ml

—

Injuries to the hip and thigh

293

2363

1.12

1.19

1.1

2.07

1.90

u/ml

0.13

163

1205

Laparoscopic right hemicolectomy

109

1.66

1.18

1.1

1.0

0.08

1.51

u/ml

—

Benign paroxysmal vertigo

160

1368

1.17

1.18

1.1

1.70

1.24

u/ml

0.31

656

Pervasive developmental disorders excl. Autism + Asperger

316

0.64

1.18

1.0

1.2

0.99

2.63

u/ml

1.11

242

Other and unspecified nail disorders

1.72

1.18

1.1

0.09

1.79

u/ml

—

Algoneurodystrophy

248

1.42

1.17

1.1

0.18

2.05

u/ml

4.14

128

Benign intracranial hypertension

110

1.67

1.17

1.1

1.84

1.73

u/ml

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

748

1.23

1.17

1.0

1.1

1.28

1.52

u/ml

0.19

347

Congenital malformations of great arteries

429

0.70

1.17

1.1

1.2

1.73

3.41

u/ml

0.91

323

Nontoxic multinodular goitre

775

1.23

1.17

1.0

1.1

0.66

1.27

u/ml

0.94

355

Angina pectoris

183

1410

0.86

1.16

1.1

1.0

1.12

0.98

u/ml

0.13

648

Other functional intestinal disorders

369

3094

1.11

1.16

1.1

1.35

2.13

u/ml

1.65

197

1669

Intentional self-harm by jumping from a high place

0.00

1.16

0.0

1.0

—

0.33

—

Osteomyelitis

274

1.39

1.15

1.1

0.87

1.46

u/ml

0.69

147

Cysts of oral region, not elsewhere classified

334

1.35

1.15

1.1

0.86

1.90

u/ml

1.41

178

Generalized epilepsy, strict definition

241

1.43

1.15

1.2

1.15

2.58

u/ml

0.84

145

Fall on and from stairs and steps

193

1679

1.15

1.1

2.60

1.87

u/ml

0.37

113

852

Basal cell carcinoma, including avohilmo

142

1152

0.85

1.15

1.1

0.26

0.95

u/ml

3.79

543

Convergent concomitant strabismus

610

0.75

1.15

1.0

1.1

5.79

1.78

u/ml

0.74

338

Amputation

235

0.59

1.14

1.1

0.37

1.20

u/ml

—

117

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

235

0.59

1.14

1.0

1.1

2.88

1.19

u/ml

—

115

Other disorders of fluid, electrolyte and acid-base balance

106

1215

0.83

1.14

1.1

0.63

1.27

u/ml

1.60

593

Alcohol abuse, main dg

100

1209

0.82

1.14

1.2

1.1

3.07

2.04

u/ml

0.43

608

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

127

1.60

1.13

1.2

1.1

3.55

2.18

u/ml

0.16

Other hammer toe(s) (acquired)

461

1.28

1.13

1.1

1.0

0.71

1.13

u/ml

0.62

218

Other specified/unspecified hearing loss

292

1.37

1.13

1.1

0.41

1.64

u/ml

2.29

159

Other and unspecified nerve root and plexus disorders, also in other diseases

149

1273

1.17

1.13

1.0

1.1

2.89

1.44

u/ml

0.60

606

Hernia of abdominal wall

298

2669

1.12

1.13

1.1

2.20

1.45

u/ml

0.66

154

1286

Juvenile osteochondrosis

336

1.35

1.13

1.0

1.1

4.11

2.31

u/ml

0.22

178

Graves ophthalmopathy, strict

111

1.64

1.12

1.0

0.92

1.65

u/ml

—

Postmenopausal bleeding

123

547

1.20

1.12

1.0

1.29

1.07

u/ml

0.09

246

Fracture of shoulder and upper arm

210

2387

0.88

1.12

1.1

1.09

2.29

u/ml

3.11

103

1285

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

236

2086

1.13

1.12

1.1

0.92

2.01

u/ml

3.05

119

1034

Other congenital malformations

126

1063

1.19

1.12

1.1

2.41

2.72

u/ml

0.15

624

Hordeolum and other deep inflammation of eyelid

441

1.30

1.11

1.1

2.39

1.85

u/ml

0.16

240

Cystic kidney disease

220

0.59

1.11

1.0

1.1

0.46

2.45

u/ml

—

129

Type of accident

264

2352

1.12

1.11

1.1

1.80

2.15

u/ml

0.37

152

1227

Enlarged lymph nodes

129

1092

1.18

1.10

1.1

3.11

1.96

u/ml

0.70

563

Measles

1.75

1.10

1.1

1.0

5.85

2.60

u/ml

—

Contact with heat and hot substances

442

1.30

1.10

1.0

1.1

6.51

2.16

u/ml

1.05

247

Acute generalized exanthematous pustulosis

277

1.38

1.10

1.1

5.46

2.06

u/ml

0.43

148

Parkinson's disease, strict definition

232

0.60

1.09

1.0

0.64

1.03

u/ml

—

120

Drug-induced cataract

112

1.62

1.09

1.2

1.0

0.95

1.87

u/ml

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

1.73

1.09

1.1

0.15

0.52

u/ml

—

Hyperparathyroidism

542

1.26

1.08

1.1

1.0

0.37

1.15

u/ml

1.87

263

Glomerular diseases

1049

0.82

1.08

1.0

1.1

1.71

1.58

u/ml

0.06

554

Bulimia nervosa (incl. atypical)

444

1.29

1.08

1.2

1.1

0.94

2.02

u/ml

1.51

216

Premenstrual syndrome

105

1.64

1.07

1.1

1.80

1.59

u/ml

—

Other disorders of breast and lactation associated with childbirth

203

1.45

1.07

1.1

1.14

1.48

u/ml

0.18

Calculus of kidney and ureter

169

1467

1.15

1.06

1.1

2.06

1.47

u/ml

0.32

718

Bitten or struck by other mammals

126

1070

1.18

1.05

1.1

2.24

1.96

u/ml

0.12

537

Vascular disorders of the intestines

113

1.60

1.05

1.1

1.0

0.21

1.72

u/ml

—

Long labour

327

2531

1.11

1.05

1.1

1.26

2.03

u/ml

1.77

161

1201

Respiratory insufficiency

105

1.62

1.05

1.1

1.0

3.76

0.74

u/ml

—

Corns and callosities

289

0.66

1.04

1.1

2.03

1.77

u/ml

—

145

Later onset COPD

242

1.35

1.04

1.0

0.26

0.39

u/ml

0.41

128

Postprocedural disorders of nervous system

734

0.79

1.04

1.1

0.98

1.69

u/ml

0.86

361

Abnormal findings on diagnostic imaging of central nervous system

306

1.35

1.04

1.0

1.1

3.82

2.10

u/ml

0.28

159

Acute pancreatitis

956

0.81

1.04

1.1

1.15

1.62

u/ml

0.52

441

Pedal cyclist injured in collision with pedestrian or animal

2.30

1.04

1.0

0.78

0.36

u/ml

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Horse dander IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS